<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Aging Neurosci</journal-id><journal-id journal-id-type="iso-abbrev">Front Aging Neurosci</journal-id><journal-id journal-id-type="pmc-domain-id">1239</journal-id><journal-id journal-id-type="pmc-domain">frontagineuro</journal-id><journal-id journal-id-type="publisher-id">Front. Aging Neurosci.</journal-id><journal-title-group><journal-title>Frontiers in Aging Neuroscience</journal-title></journal-title-group><issn pub-type="epub">1663-4365</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10483235</article-id><article-id pub-id-type="pmcid-ver">PMC10483235.1</article-id><article-id pub-id-type="pmcaid">10483235</article-id><article-id pub-id-type="pmcaiid">10483235</article-id><article-id pub-id-type="pmid">37693648</article-id><article-id pub-id-type="doi">10.3389/fnagi.2023.1223977</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Neuroscience</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Impact of common ALDH2 inactivating mutation and alcohol consumption on Alzheimer&#8217;s disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Seike</surname><given-names initials="T">Takuya</given-names></name><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/2145787/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chen</surname><given-names initials="CH">Che-Hong</given-names></name><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/2400118/overview"/></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Mochly-Rosen</surname><given-names initials="D">Daria</given-names></name><xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/1049574/overview"/></contrib></contrib-group><aff><institution>Department of Chemical and Systems Biology, Stanford University School of Medicine</institution>, <addr-line>Stanford, CA</addr-line>, <country>United States</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Anamitra Ghosh, Wave Life Sciences Ltd., United States</p></fn><fn fn-type="edited-by"><p>Reviewed by: Baijayanti Ghosh, Baylor College of Medicine, United States; Firoz Akhter, Stony Brook University, United States</p></fn><corresp id="c001">*Correspondence: Daria Mochly-Rosen, <email>mochly@stanford.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>24</day><month>8</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>15</volume><issue-id pub-id-type="pmc-issue-id">427329</issue-id><elocation-id>1223977</elocation-id><history><date date-type="received"><day>16</day><month>5</month><year>2023</year></date><date date-type="accepted"><day>07</day><month>8</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>08</day><month>09</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-07-05 15:25:37.117"><day>05</day><month>07</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2023 Seike, Chen and Mochly-Rosen.</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Seike, Chen and Mochly-Rosen</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fnagi-15-1223977.pdf"/><abstract><p>Aldehyde dehydrogenase 2 (ALDH2) is an enzyme found in the mitochondrial matrix that plays a central role in alcohol and aldehyde metabolism. A common ALDH2 polymorphism in East Asians descent (called ALDH2*2 or E504K missense variant, SNP ID: rs671), present in approximately 8% of the world&#8217;s population, has been associated with a variety of diseases. Recent meta-analyses support the relationship between this ALDH2 polymorphism and Alzheimer&#8217;s disease (AD). And AD-like pathology observed in ALDH2<sup>&#8211;/&#8211;</sup> null mice and ALDH2*2 overexpressing transgenic mice indicate that ALDH2 deficiency plays an important role in the pathogenesis of AD. Recently, the worldwide increase in alcohol consumption has drawn attention to the relationship between heavy alcohol consumption and AD. Of potential clinical significance, chronic administration of alcohol in ALDH2*2/*2 knock-in mice exacerbates the pathogenesis of AD-like symptoms. Therefore, ALDH2 polymorphism and alcohol consumption likely play an important role in the onset and progression of AD. Here, we review the data on the relationship between ALDH2 polymorphism, alcohol, and AD, and summarize what is currently known about the role of the common ALDH2 inactivating mutation, ALDH2*2, and alcohol in the onset and progression of AD.</p></abstract><kwd-group><kwd>Alzheimer&#8217;s disease</kwd><kwd>ALDH2</kwd><kwd>alcohol</kwd><kwd>aldehyde</kwd><kwd>4-hydroxynonenal</kwd><kwd>formaldehyde</kwd><kwd>Alda-1</kwd><kwd>blood brain barrier</kwd></kwd-group><funding-group><funding-statement>This work was supported by the NIAAA11147 to DM-R.</funding-statement></funding-group><counts><fig-count count="5"/><table-count count="1"/><equation-count count="0"/><ref-count count="193"/><page-count count="15"/><word-count count="13084"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Alzheimer&#8217;s Disease and Related Dementias</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="S1"><title>Introduction</title><p>The world population is aging, which is of particular concern because of increase in the number of dementia patients (<xref rid="B64" ref-type="bibr">Khan et al., 2020</xref>); one of 5 people over the age of 75 are expected to have Alzheimer&#8217;s disease (AD) (<xref rid="B48" ref-type="bibr">Hebert et al., 2013</xref>). Patients suffering from dementia, a progressive neurodegenerative disease characterized by cognitive decline, have difficulty living independently and require continuous support from family and healthcare professionals (<xref rid="B73" ref-type="bibr">Lane et al., 2018</xref>; <xref rid="B132" ref-type="bibr">Scheltens et al., 2021</xref>). As a result, dementia has become a serious problem that not only causes severe suffering to the patients, but also increases the burden of care and medical costs (<xref rid="B165" ref-type="bibr">Wang et al., 2017</xref>).</p><p>First reported by Alois Alzheimer in 1907 (<xref rid="B4" ref-type="bibr">Alzheimer, 1907</xref>), AD is the leading cause of dementia, accounting for 50&#8211;75% of all dementia cases (<xref rid="B73" ref-type="bibr">Lane et al., 2018</xref>). The neuropathological features of AD include synapse loss, selective neuronal cell death, reduction of certain neurotransmitters, and deposition of abnormal proteins inside and outside neurons (<xref rid="B91" ref-type="bibr">Masters et al., 2015</xref>). Various factors have been implicated in the pathogenesis of AD, including abnormal amyloid-&#946; (A&#946;) metabolism, tau hyperphosphorylation, oxidative stress, and increases in reactive glia and microglia, the nature of which remains largely unknown (<xref rid="B165" ref-type="bibr">Wang et al., 2017</xref>).</p><p>Aldehyde dehydrogenase 2 (ALDH2), a member of the ALDH multigene family, is an enzyme found in the mitochondrial matrix that plays a central role in alcohol metabolism (<xref rid="B38" ref-type="bibr">Edenberg and Foroud, 2013</xref>). It is involved not only in the metabolism of acetaldehyde generated by alcohol consumption (<xref rid="B67" ref-type="bibr">Klyosov et al., 1996</xref>), but also in the metabolism of endogenous and exogenous aldehydes, such as 4-hydroxynonenal (4-HNE), formaldehyde (FA), and malondialdehyde (MDA) (<xref rid="B23" ref-type="bibr">Chen et al., 2019</xref>; <xref rid="B125" ref-type="bibr">Rodr&#237;guez-Zavala et al., 2019</xref>; <xref rid="B35" ref-type="bibr">Dingler et al., 2020</xref>; <xref rid="B98" ref-type="bibr">Mu et al., 2021</xref>). A well-characterized ALDH2 polymorphism, ALDH2*2, that results in reduced or loss of ALDH2 activity, has attracted attention for its association with various diseases including alcohol flushing (<xref rid="B25" ref-type="bibr">Chen C. H. et al., 2022</xref>), malignancy (<xref rid="B186" ref-type="bibr">Zhang and Fu, 2021</xref>), cardiovascular disease (<xref rid="B23" ref-type="bibr">Chen et al., 2019</xref>), and liver disease (<xref rid="B186" ref-type="bibr">Zhang and Fu, 2021</xref>; <xref rid="B135" ref-type="bibr">Seike et al., 2022</xref>), and evidence that it is also associated with AD has recently been accumulating.</p><p>The effects of alcohol on the human health are clear, as alcohol consumption results in 139 million disability-adjusted life years worldwide (<xref rid="B95" ref-type="bibr">Meza et al., 2022</xref>). Despite regional differences, global alcohol consumption is still increasing (<xref rid="B87" ref-type="bibr">Manthey et al., 2019</xref>), so is the alarming increase in some alcohol-related diseases and causes of death, such as mental disorders, liver cirrhosis, and cancer (<xref rid="B129" ref-type="bibr">Rumgay et al., 2021</xref>). Studies have shown that the ALDH2 polymorphism, ALDH2*2, is protective against alcoholism because it acts in a suppressive manner against excessive alcohol intake due to the discomfort caused by drinking (<xref rid="B38" ref-type="bibr">Edenberg and Foroud, 2013</xref>). However, more recent data show that among excessive alcohol consumers, approximately 20% of people carried the ALDH2 deficient polymorphism (<xref rid="B21" ref-type="bibr">Chen et al., 1999</xref>; <xref rid="B181" ref-type="bibr">Yokoyama et al., 2002</xref>; <xref rid="B15" ref-type="bibr">Brooks et al., 2009</xref>). Therefore, the health effect of alcohol consumption in carriers of ALDH2*2 gene cannot be ignored.</p><p>The relationship between alcohol consumption and neurodegeneration has been studied for some time (<xref rid="B161" ref-type="bibr">Venkataraman et al., 2017</xref>; <xref rid="B75" ref-type="bibr">Le&#243;n et al., 2021</xref>; <xref rid="B120" ref-type="bibr">Ramos et al., 2022</xref>), and chronic and heavy alcohol consumption may accelerate brain aging and increase the risk of dementia and AD (<xref rid="B75" ref-type="bibr">Le&#243;n et al., 2021</xref>; <xref rid="B162" ref-type="bibr">Visontay et al., 2021</xref>). What then is the role of alcohol in the pathogenesis of AD under conditions of reduced ALDH2 activity? We have previously shown that daily exposure of ALDH2*2/*2 knock-in mice (E504K missense) to ethanol causes mitochondrial dysfunction, oxidative stress, and increased aldehyde load in the brain (<xref rid="B57" ref-type="bibr">Joshi et al., 2019</xref>). In addition, increased AD-related proteins A&#946;, phosphorylation of neurofilament tau, and neuroinflammation were also exacerbated in the brains of ethanol-exposed ALDH2*2/*2 knock-in mice compared to wild type (WT) mice (<xref rid="B57" ref-type="bibr">Joshi et al., 2019</xref>). If confirmed in humans, these findings strongly suggest that chronic and excessive ethanol consumption, especially among ALDH2*2 carriers, may accelerate the progression and exacerbate the pathogenesis of AD in humans. Recent studies showing that neurofilament light chains, a marker of neuroaxonal injury, are more increased in alcohol dependence patients with the ALDH2 deficient polymorphism provide more support for this hypothesis (<xref rid="B52" ref-type="bibr">Huang et al., 2023</xref>).</p><p>About 540 million people, of East Asians ancestry, have markedly reduced ALDH2 activity due to a missense mutation in its gene. This indicates that approximately 8% of the world&#8217;s population is more vulnerable and susceptible to exposure to toxic acetaldehyde (<xref rid="B15" ref-type="bibr">Brooks et al., 2009</xref>). So, will increased global alcohol consumption (<xref rid="B87" ref-type="bibr">Manthey et al., 2019</xref>), along with a large ALDH2 polymorphic drinking population, spur an increase in dementia patients? Clarification of this issue could lead to a better understanding of modifiable risk factors for AD. Understand the modifiable risk factors that contribute to the progression of AD pathology together with effective ALDH2 deficiency education campaign may lead to a reduction in the future increase in the number of AD patients. Therefore, it is necessary to piece together fragmentary information, such as the relationship between ALDH2 inactivity and AD and the relationship between alcohol consumption and AD, to understand their influence on the pathogenesis of AD.</p></sec><sec id="S2"><title>Epidemiological data on ALDH2 polymorphism and Alzheimer&#8217;s disease</title><p>A cross-sectional community-based study of 690 Koreans aged 65 years and older showed no association between ALDH2*2 and AD (<xref rid="B65" ref-type="bibr">Kim et al., 2004</xref>). Another study of 510 Koreans aged 65 years or older observed for 2.4 years also found no significant association between ALDH2*2 and incidence of dementia, AD, or cognitive decline (<xref rid="B140" ref-type="bibr">Shin et al., 2005</xref>).</p><p>In contrast, genotype frequencies of the ALDH2*2 allele were significantly higher in 447 Japanese AD patients compared with an equal number of sex-, age-, and region-matched non-affected subjects (<xref rid="B107" ref-type="bibr">Ohta et al., 2004</xref>). In an analysis of data from 1949 Chinese individuals aged 90 years and older, the ALDH2*2 polymorphism was associated with cognitive dysfunction (<xref rid="B56" ref-type="bibr">Jin et al., 2021</xref>). In the Japanese cohort, the frequency of ALDH2*2 was significantly increased in AD subjects compared to the target group, with an odds ratio of 1.41 (<xref rid="B159" ref-type="bibr">Ueno et al., 2022</xref>). That study also performed a meta-analysis (1,824 cases, 4,300 controls) including six additional previous case-control studies in Asians (<xref rid="B59" ref-type="bibr">Kamino et al., 2000</xref>; <xref rid="B163" ref-type="bibr">Wang et al., 2008</xref>; <xref rid="B190" ref-type="bibr">Zhou et al., 2010</xref>; <xref rid="B70" ref-type="bibr">Komatsu et al., 2014</xref>; <xref rid="B86" ref-type="bibr">Ma and Lu, 2016</xref>; <xref rid="B171" ref-type="bibr">Wu Y. Y. et al., 2021</xref>) and found that the ALDH2*2 allele was a risk for AD, with an odds ratio of 1.38 (<xref rid="B159" ref-type="bibr">Ueno et al., 2022</xref>).</p></sec><sec id="S3"><title>Natural history of mice with reduced ALDH2 activity</title><p>Animal models that mimic AD express some of the pathological features of human AD (<xref rid="B3" ref-type="bibr">Akhtar et al., 2022</xref>). ALDH2<sup>&#8211;/&#8211;</sup> null mice showed progressive cognitive dysfunction from around 3.5&#8211;4 months, with AD-like pathological changes, including increased 4-HNE protein adducts in the hippocampus (<xref rid="B37" ref-type="bibr">D&#8217;Souza et al., 2015</xref>) and cortex (<xref rid="B68" ref-type="bibr">Knopp et al., 2020</xref>), A&#946; deposition in the brain, tau phosphorylation, increased activated caspase, and defective cAMP-response element binding protein (CREB) signaling (<xref rid="B37" ref-type="bibr">D&#8217;Souza et al., 2015</xref>; <xref rid="B85" ref-type="bibr">Luo et al., 2016</xref>; <xref rid="B68" ref-type="bibr">Knopp et al., 2020</xref>). In ALDH2<sup>&#8211;/&#8211;</sup> null mice, compared to WT mice, a marked decrease in apical and basal dendritic length, dendritic complexity, and spine density of dorsal hippocampal CA1 pyramidal cells began to be observed around 6 months and was maintained through the age of 12 months. This neuronal degeneration was associated with oxidative stress (<xref rid="B92" ref-type="bibr">Mehder et al., 2020</xref>, <xref rid="B93" ref-type="bibr">2021</xref>). The progressive age-related decline in hippocampus-dependent working and spatial memory in ALDH2<sup>&#8211;/&#8211;</sup> null mice from around 3.5&#8211;4 months (<xref rid="B37" ref-type="bibr">D&#8217;Souza et al., 2015</xref>) was associated with a decrease in synaptic proteins which were important for learning and memory in the hippocampus (<xref rid="B68" ref-type="bibr">Knopp et al., 2020</xref>; <xref rid="F1" ref-type="fig">Figure 1A</xref>).</p><fig position="float" id="F1" orientation="portrait"><label>FIGURE 1</label><caption><p>Schematic representation of behavior cellular and molecular changes associated with AD-like symptoms in mice. <bold>(A)</bold> Natural history of factors involved in the pathogenesis of Alzheimer&#8217;s disease (AD) in ALDH2<sup>&#8211;/&#8211;</sup> mice. <bold>(B)</bold> Natural history of factors involved in the pathogenesis of AD in ALDH2*2 overexpressing (OE) transgenic mice. <bold>(C)</bold> Natural history of factors involved in the pathogenesis of mice expressing AD-associated amyloid precursor protein (APP). <bold>(D)</bold> Natural history of factors involved in the pathogenesis of mice expressing APP, and overexpressing ALDH2*2. 4-HNE, 4-hydroxynon-enal; A&#946;, amyloid &#946;; pTau, phosphorylated tau; Casp-3, Caspase 3; pCREB, phosphorylated cyclic-AMP response element binding protein.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fnagi-15-1223977-g001.jpg"/></fig><p>In transgenic (Tg) mice overexpressing ALDH2*2 (ALDH2*2 OE), aging was accompanied by increased deposition of 4-HNE in the brain, decreased pyramidal cells, increased glial cell activation, and at 12&#8211;18 months, tau phosphorylation and learning memory deficits became apparent in the hippocampus (<xref rid="B105" ref-type="bibr">Ohsawa et al., 2008</xref>; <xref rid="F1" ref-type="fig">Figure 1B</xref>). In ALDH2*2 OE mice, it took longer for pathological changes to develop compared to ALDH2<sup>&#8211;/&#8211;</sup> null mice (<xref rid="B37" ref-type="bibr">D&#8217;Souza et al., 2015</xref>). Furthermore, in mice where the ALDH2*2 E504K missense mutation was knocked-in (ALDH2*2/*2 KI), increased mitochondrial reactive oxygen species (ROS), A&#946; accumulation, and caspase 3 activation at 6 months was observed (These mice are not included in the <xref rid="F1" ref-type="fig">Figure 1B</xref> because of incomplete data) (<xref rid="B57" ref-type="bibr">Joshi et al., 2019</xref>). These three mouse models, two mimicking the mutations in human with residual ALDH2 activity of about 2&#8211;5%, and the other &#8211; with complete absence of ALDH2, show that a reduction in ALDH2 activity alone can mimic AD-like pathology, indicating the importance of reduced ALDH2 activity in AD.</p></sec><sec id="S4"><title>Acceleration of AD pathology due to decreased ALDH2 activity in mice</title><p>Double transgenic (APP/ALDH2*2 OE) mice from a cross between Tg2576 mice expressing a mutant form of human amyloid precursor protein (APP) and DAL mice over expressing the mutant form of ALDH2 (ALDH2*2 OE) showed cognitive dysfunction already at 3 months, accelerated gliosis from 6 months, tau phosphorylation from around 9 months, and A&#946; accumulation beginning around 6 months that increased significantly after 12 months (<xref rid="B60" ref-type="bibr">Kanamaru et al., 2015</xref>). Pathological changes in APP/ALDH2*2 OE mice were observed earlier and were significantly more pronounced compared to APP mice (<xref rid="B60" ref-type="bibr">Kanamaru et al., 2015</xref>), which showed cognitive dysfunction from 6 months (<xref rid="B167" ref-type="bibr">Westerman et al., 2002</xref>), A&#946; accumulation from 9 to 12 months (<xref rid="B61" ref-type="bibr">Kawarabayashi et al., 2001</xref>), no tau phosphorylation (<xref rid="B12" ref-type="bibr">Bilkei-Gorzo, 2014</xref>), and no astrocyte activation (<xref rid="B60" ref-type="bibr">Kanamaru et al., 2015</xref>; <xref rid="F1" ref-type="fig">Figures 1C, D</xref>). These results indicate an earlier onset of memory impairment and accelerated AD-like pathology in APP/ALDH2*2 OE mice with reduced activity of ALDH2 than in APP mice (<xref rid="B60" ref-type="bibr">Kanamaru et al., 2015</xref>). In addition, overexpressing wildtype (active) ALDH2 in APP/PS1 mice (ALDH2 OE/APP/PS1) reduced cognitive dysfunction compared to APP/PS1 mice. This indicates that increased activity of ALDH2 can counteract the pathogenesis of AD (<xref rid="B192" ref-type="bibr">Zhu et al., 2022</xref>).</p></sec><sec id="S5"><title>Relationship between oxidative stress and the pathogenesis of AD in mice</title><p>The above animal models suggest that decreased ALDH2 activity increases the pathogenesis of AD and promotes its progression in predisposed individuals (<xref rid="F1" ref-type="fig">Figure 1</xref>) and that increased ALDH2 activity can reduce this pathogenesis. What molecular mechanisms underlie this phenomenon? ALDH2 is an important enzyme responsible for the metabolism of both endogenous and exogenous toxic aldehydes, including 4-HNE, MDA, acetaldehyde and FA (<xref rid="B153" ref-type="bibr">Teng et al., 2001</xref>; <xref rid="B24" ref-type="bibr">Chen et al., 2016</xref>; <xref rid="B35" ref-type="bibr">Dingler et al., 2020</xref>; <xref rid="B78" ref-type="bibr">Li T. et al., 2021</xref>; <xref rid="B98" ref-type="bibr">Mu et al., 2021</xref>; <xref rid="B71" ref-type="bibr">Kou et al., 2022</xref>), and decreased ALDH2 activity is associated with increased vulnerability to oxidative stress (<xref rid="B106" ref-type="bibr">Ohsawa et al., 2003</xref>). Indeed, oxidative damage has been reported to precede the appearance of A&#946; groups and neurofibrillary tangles in AD patients and different AD animal models (<xref rid="B118" ref-type="bibr">Pratic&#242; et al., 2001</xref>; <xref rid="B124" ref-type="bibr">Resende et al., 2008</xref>), indicating that oxidative stress is an important change that occurs early in AD disease (<xref rid="B63" ref-type="bibr">Keller et al., 2005</xref>; <xref rid="B17" ref-type="bibr">Butterfield et al., 2006</xref>; <xref rid="B117" ref-type="bibr">Pratic&#242;, 2008</xref>; <xref rid="B110" ref-type="bibr">Padurariu et al., 2013</xref>). In ALDH2<sup>&#8211;/&#8211;</sup> null mice (<xref rid="B37" ref-type="bibr">D&#8217;Souza et al., 2015</xref>; <xref rid="B68" ref-type="bibr">Knopp et al., 2020</xref>; <xref rid="B93" ref-type="bibr">Mehder et al., 2021</xref>) and ALDH2*2 OE Tg mice (<xref rid="B105" ref-type="bibr">Ohsawa et al., 2008</xref>), 4-HNE in the brain is found to be increased early and prior to AD-like symptoms (<xref rid="F1" ref-type="fig">Figures 1A, B</xref>). Therefore, it is necessary to understand the role of toxic aldehydes, such as 4-HNE, acetaldehyde and FA, and decreased ALDH2 activity on AD.</p></sec><sec id="S6"><title>Effect of 4-HNE on the pathogenesis of AD in humans and mice</title><p>4-HNE is elevated in ventricular fluid (<xref rid="B83" ref-type="bibr">Lovell et al., 1997</xref>) and brain (<xref rid="B131" ref-type="bibr">Sayre et al., 1997</xref>; <xref rid="B90" ref-type="bibr">Markesbery and Lovell, 1998</xref>; <xref rid="B169" ref-type="bibr">Williams et al., 2006</xref>; <xref rid="B41" ref-type="bibr">Fukuda et al., 2009</xref>; <xref rid="B123" ref-type="bibr">Reed et al., 2009</xref>) of AD patients. 4-HNE is also increased in the brain tissue of ALDH2<sup>&#8211;/&#8211;</sup> null mice (<xref rid="B37" ref-type="bibr">D&#8217;Souza et al., 2015</xref>; <xref rid="B68" ref-type="bibr">Knopp et al., 2020</xref>; <xref rid="B93" ref-type="bibr">Mehder et al., 2021</xref>) and ALDH2*2 OE Tg mice (<xref rid="B105" ref-type="bibr">Ohsawa et al., 2008</xref>; <xref rid="F1" ref-type="fig">Figures 1A, B</xref>) and in ALDH2*2/*2 KI mice (<xref rid="B57" ref-type="bibr">Joshi et al., 2019</xref>). 4-HNE levels in the brain are also increased in senescence accelerated mice P8 (SAMP8), an aging phenotype characterized by memory impairment and behavioral changes (<xref rid="B42" ref-type="bibr">Gri&#241;an-Ferr&#233; et al., 2016</xref>), and in 5XFAD mice, an early-onset transgenic mouse model of AD (<xref rid="B43" ref-type="bibr">Gri&#241;&#225;n-Ferr&#233; et al., 2016</xref>; <xref rid="B141" ref-type="bibr">Shin et al., 2020</xref>). Interestingly, ALDH2 expression is lower in the hippocampus of SAMP8 at 2 and 9 months relative to age-matched control strain, SAMR1 (<xref rid="B42" ref-type="bibr">Gri&#241;an-Ferr&#233; et al., 2016</xref>), and in the brain of 5XFAD mice at 8 months (<xref rid="B43" ref-type="bibr">Gri&#241;&#225;n-Ferr&#233; et al., 2016</xref>) relative to age-matched WT mice. These data indicate that 4-HNE is increased in the context of AD and that one of the reasons for this may be the reduced ALDH2 activity.</p><p>The toxicity of 4-HNE is due to changes in cellular function secondary to its ability to readily react with various cellular components with nucleophilic thiol (-SH), amino (-NH2) groups and deoxyguanosine residues, such as deoxyribonucleic acid (DNA) and proteins (<xref rid="B51" ref-type="bibr">Huang et al., 2010</xref>; <xref rid="B113" ref-type="bibr">Perluigi et al., 2012</xref>; <xref rid="B32" ref-type="bibr">Dalleau et al., 2013</xref>). Redox proteomic studies have identified proteins involved in metabolism, cell signaling, pH regulation, neuronal communication, antioxidation and detoxification, neurotransmitter regulation, tau phosphorylation and regulation of APP processing in the context of AD and neurodegeneration (<xref rid="B114" ref-type="bibr">Perluigi et al., 2009</xref>; <xref rid="B146" ref-type="bibr">Sultana et al., 2013</xref>; <xref rid="B33" ref-type="bibr">Di Domenico et al., 2017</xref>), and thus indicating that oxidative modifications by 4-HNE likely play an important role in the pathogenesis of AD.</p><p>The molecular mechanisms by which 4-HNE is involved in the pathogenesis of AD are summarized in <xref rid="F2" ref-type="fig">Figure 2A</xref>. The reduced DNA binding ability of histones and altered chromatin structure due to oxidative modification of 4-HNE increases the vulnerability of DNA to oxidation in the brains of AD patients (<xref rid="B36" ref-type="bibr">Drake et al., 2004</xref>) and may affect transcription, thus leading to accelerated aging and neurodegeneration (<xref rid="B13" ref-type="bibr">Bohr, 2002</xref>). 4-HNE leads to dysfunction of glucose and glutamate transporters, mitochondrial dysfunction, and reduced adenosine triphosphate (ATP) levels, and is involved in synaptic degeneration (<xref rid="B62" ref-type="bibr">Keller et al., 1997</xref>). Decrease in neuronal Na<sup>+</sup>/K<sup>+</sup>ATPase activity and increase in intracellular free calcium concentration by 4-HNE results in increased neuronal vulnerability (<xref rid="B89" ref-type="bibr">Mark et al., 1997</xref>). In addition, 4-HNE-induced lysosomal membrane disruption by cleavage of heat shock protein 70.1 is involved in neuronal degeneration (<xref rid="B177" ref-type="bibr">Yamashima et al., 2020</xref>, <xref rid="B176" ref-type="bibr">2022</xref>, <xref rid="B178" ref-type="bibr">2023</xref>). Decreased activity of choline acetyltransferase by 4-HNE has been implicated in memory impairment (<xref rid="B16" ref-type="bibr">Bruce-Keller et al., 1998</xref>). 4-HNE enhances the production of A&#946; through increased activity of &#947;-secretase (<xref rid="B45" ref-type="bibr">Gwon et al., 2012</xref>) and &#946;-secretase (<xref rid="B148" ref-type="bibr">Tamagno et al., 2002</xref>, <xref rid="B149" ref-type="bibr">2005</xref>), and also forms an adduct with neprilysin, an amyloid-degrading enzyme, reducing enzyme activity and A&#946; turnover (<xref rid="B164" ref-type="bibr">Wang et al., 2003</xref>). Finally, changes in A&#946; disposition through increased A&#946; formation (<xref rid="B80" ref-type="bibr">Liu et al., 2008</xref>), aggregation (<xref rid="B27" ref-type="bibr">Chen et al., 2006</xref>; <xref rid="B143" ref-type="bibr">Siegel et al., 2007</xref>), decreased catabolism (<xref rid="B166" ref-type="bibr">Wang et al., 2009</xref>), and clearance (<xref rid="B142" ref-type="bibr">Shringarpure et al., 2000</xref>; <xref rid="B109" ref-type="bibr">Owen et al., 2010</xref>) are mediated by 4-HNE.</p><fig position="float" id="F2" orientation="portrait"><label>FIGURE 2</label><caption><p><bold>(A)</bold> Summary of the effects of 4-hydroxynonenal (4-HNE) in the pathogenesis of Alzheimer&#8217;s disease (AD). <bold>(B)</bold> Summary of the effects of formaldehyde in the pathogenesis of AD. Hsp 70.1, heat shock protein 70.1; LMP, lysosomal membrane permeabilization; A&#946;, amyloid &#946;; ChAT, choline acetyltransferase; ROS, reactive oxygen species; ATP, adenosine triphosphate; NMDAR, N-methyl-D-aspartate receptor.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fnagi-15-1223977-g002.jpg"/></fig></sec><sec id="S7"><title>Effect of formaldehyde on the pathogenesis of AD</title><p>FA is elevated in the brains (<xref rid="B47" ref-type="bibr">He et al., 2010</xref>; <xref rid="B157" ref-type="bibr">Tong et al., 2011</xref>) and urine (<xref rid="B26" ref-type="bibr">Chen F. et al., 2022</xref>) of AD patients, in the brains of aged rats (<xref rid="B155" ref-type="bibr">Tong et al., 2013b</xref>), APP/PS1 mice (<xref rid="B184" ref-type="bibr">Yue et al., 2019</xref>) that expresses APP and a mutant human presenilin 1 (<xref rid="B82" ref-type="bibr">Lok et al., 2013</xref>), and in ALDH2<sup>&#8211;/&#8211;</sup> null mice (<xref rid="B150" ref-type="bibr">Tan et al., 2018</xref>; <xref rid="B2" ref-type="bibr">Ai et al., 2019</xref>). Administration of FA to adult rats mimicked age-related memory decline in aging rats (<xref rid="B154" ref-type="bibr">Tong et al., 2013a</xref>; <xref rid="B150" ref-type="bibr">Tan et al., 2018</xref>). Administration of an inhibitor (Daidzin) of ALDH2 to rats increased hippocampal FA levels (<xref rid="B155" ref-type="bibr">Tong et al., 2013b</xref>). The accumulation of FA in the brain of ALDH2<sup>&#8211;/&#8211;</sup> null mice was associated with hyperglycemia and cognitive impairment (<xref rid="B150" ref-type="bibr">Tan et al., 2018</xref>). Together, these results suggest that the accumulation of FA in the brain leads to cognitive dysfunction, and that reduced ALDH2 activity is involved in the accumulation of FA in the brain.</p><p>The possible molecular mechanisms by which FA is involved in the pathogenesis of AD are summarized in <xref rid="F2" ref-type="fig">Figure 2B</xref>. FA may contribute to age-related cognitive decline by impairing DNA methyltransferase function (<xref rid="B156" ref-type="bibr">Tong et al., 2015</xref>), causing an imbalance (<xref rid="B96" ref-type="bibr">Miller et al., 2010</xref>) between DNA methylation and demethylation, a critical step in memory formation (<xref rid="B154" ref-type="bibr">Tong et al., 2013a</xref>; <xref rid="B78" ref-type="bibr">Li T. et al., 2021</xref>). FA acts synergistically with A&#946; to promote ROS generation by enhancing calcium influx, it inhibits cyclooxygenase activity, and decreases ATP production, the amount of coenzyme Q10 in mitochondria, resulting in neuronal cell death (<xref rid="B71" ref-type="bibr">Kou et al., 2022</xref>). FA also reduces acetylcholine levels by inhibiting choline acetyltransferase (<xref rid="B187" ref-type="bibr">Zhang et al., 2019</xref>). N-methyl-D-aspartate receptors (NMDAR), which are composed of NR1 and NR2 or NR3 subunits, play an important role in learning and memory as well as excitatory neurotransmission and synaptic plasticity (<xref rid="B139" ref-type="bibr">Shimizu et al., 2000</xref>). Significant reductions in NR1 and NR2 expression have been observed in the hippocampus of aging rats (<xref rid="B29" ref-type="bibr">Clayton and Browning, 2001</xref>; <xref rid="B30" ref-type="bibr">Clayton et al., 2002</xref>; <xref rid="B94" ref-type="bibr">Mesches et al., 2004</xref>) and in AD patients (<xref rid="B53" ref-type="bibr">Hynd et al., 2004</xref>; <xref rid="B5" ref-type="bibr">Amada et al., 2005</xref>). FA has been reported to be involved in learning and memory control by inactivating NMDAR via NR1/NR2B, thereby suppressing hippocampal long-term potentiation (<xref rid="B155" ref-type="bibr">Tong et al., 2013b</xref>; <xref rid="B2" ref-type="bibr">Ai et al., 2019</xref>). Excess FA induces hyperphosphorylation of tau (<xref rid="B84" ref-type="bibr">Lu et al., 2013</xref>) and misfolding of tau protein via glycogen synthase kinase-3&#946; (GSK-3&#946;) (<xref rid="B40" ref-type="bibr">Elyaman et al., 2002</xref>), an important tau kinase, to form spherical amyloid-like aggregates with high cytotoxicity (<xref rid="B101" ref-type="bibr">Nie et al., 2007a</xref>,<xref rid="B102" ref-type="bibr">b</xref>). FA is a very reactive cross-linking agent in A&#946; aggregation that promotes the formation of A&#946; dimers, oligomers, and fibrils by cross-linking K28 (lysine, K) residues in the &#946;-turn of the A&#946; monomer (<xref rid="B27" ref-type="bibr">Chen et al., 2006</xref>; <xref rid="B71" ref-type="bibr">Kou et al., 2022</xref>). The accumulation of A&#946; in APP/PS1 mice is accompanied by a progressive increase in cortical FA levels, suggesting that FA may promote A&#946; accumulation (<xref rid="B184" ref-type="bibr">Yue et al., 2019</xref>).</p></sec><sec id="S8"><title>Possible improvement of cognitive dysfunction through activation of ALDH2</title><p>As discussed above, decreased ALDH2 activity is involved in the pathogenesis of AD via various pathways associated with aldehyde accumulation and regardless of the cause of pathogenesis, increased activity of ALDH2 appears to correlate with amelioration of the pathogenesis. For example, elevated level of homocysteine is an independent risk factor for AD (<xref rid="B138" ref-type="bibr">Seshadri et al., 2002</xref>; <xref rid="B160" ref-type="bibr">Van Dam and Van Gool, 2009</xref>; <xref rid="B50" ref-type="bibr">Hu et al., 2016</xref>) and exposure of homocysteine to hippocampus of rats, induces learning and memory impairment (<xref rid="B185" ref-type="bibr">Zhang et al., 2009</xref>; <xref rid="B76" ref-type="bibr">Li et al., 2014</xref>). However, hydrogen sulfide, which induced an increase in ALDH2 expression, reduced the accumulation of reactive aldehydes in the brain and improved cognitive impairment in these rats (<xref rid="B77" ref-type="bibr">Li et al., 2017</xref>). Another example is the correlation between elevated FA and AD pathology in 3XFAD mice as compared to control mice with aging. This elevation in FA levels was associated with reduced ALDH2 activity in the brain, and activation of ALDH2 with Alda-1, a small molecule enzyme activator (<xref rid="B22" ref-type="bibr">Chen et al., 2008</xref>), significantly reduced brain FA levels and improved neurological dysfunction (<xref rid="B152" ref-type="bibr">Tao et al., 2022</xref>). Similarly, overexpression of the ALDH2 gene significantly improved cognitive function in APP/PS1 AD mice (<xref rid="B179" ref-type="bibr">Yang et al., 2021</xref>) and reduced hyperglycemia and improved cognitive function by reducing FA in a mouse model of diabetes (<xref rid="B150" ref-type="bibr">Tan et al., 2018</xref>). Rat hippocampal neurons overexpressing ALDH2 by gene transfer showed resistance to 4-HNE-induced neurite damage, decreased caspase-3 protein expression, decreased ROS levels, and decreased disruption of mitochondrial transmembrane potentials (<xref rid="B9" ref-type="bibr">Bai and Mei, 2011</xref>).</p><p>Further studies showed that treatment with Alda-1, which activates ALDH2 (<xref rid="B22" ref-type="bibr">Chen et al., 2008</xref>), reduced the A&#946;-induced increase in 4-HNE, mitochondrial dysfunction, and decreased ATP in HT22 cells (<xref rid="B179" ref-type="bibr">Yang et al., 2021</xref>). Treatment of mouse microglial BV2 cells or mouse neuronal cells (Neuro-2a) with hydrogen peroxide to increase oxidative stress, resulted in increased FA, decreased ALDH2 activity, and increased pro-apoptotic protein, B-cell lymphoma-2-associated X (BAX), and all of these were ameliorated by treatment with Alda-1 (<xref rid="B152" ref-type="bibr">Tao et al., 2022</xref>). Furthermore, increased aldehydic load, oxidative stress, reduced ATP levels and increased mitochondrial dysfunction seen in fibroblasts of an AD patient that also has an ALDH2*2 mutation or overexpression of ALDH2*2 in fibroblasts derived from AD patients with ApoE &#949;4 allele relative to healthy subjects, were all reduced following treatment with Alda-1 (<xref rid="B57" ref-type="bibr">Joshi et al., 2019</xref>). Taken together, these data suggest that activation of ALDH2 is neuroprotective and may prevent cognitive dysfunction and that having reduced ALDH2 activity may render the brain more vulnerable to cognitive function decline.</p></sec><sec id="S9"><title>Epidemiological data of Alzheimer&#8217;s disease and alcohol exposure</title><p>A meta-analysis of 14,646 AD patients (<xref rid="B7" ref-type="bibr">Anstey et al., 2009</xref>) and a systematic review of 45 studies on the epidemiology of alcohol consumption and risk of dementia or cognitive decline (<xref rid="B54" ref-type="bibr">Ilomaki et al., 2015</xref>) indicated that the risk of AD was reduced in light to moderate drinkers compared to non-drinkers. However, a number of studies, as reviewed below, have shown that alcohol consumption, especially heavy amounts, is a risk for dementia. An observational study conducted in the United Kingdom (UK) over a 30-year period revealed that moderate or higher alcohol consumption increased the risk of developing hippocampal atrophy (<xref rid="B158" ref-type="bibr">Topiwala et al., 2017</xref>). An analysis of 13,342 individuals aged 40 to 73 years using UK Biobank data showed that alcohol consumption exceeding 1 drink per day was associated with a significant cognitive decline (<xref rid="B116" ref-type="bibr">Piumatti et al., 2018</xref>). Another analysis of 397 dementia cases from a UK study involving 9,087 participants aged 35&#8211;55 years with an average of 23-year follow ups showed that alcohol consumption of 14 drinks or more per week was a risk for dementia (<xref rid="B130" ref-type="bibr">Sabia et al., 2018</xref>). In 2019, an observational study of 3,021 older United States adults with a median age of 78 years and a median follow-up of 6 years showed that drinking more than 14 drinks per week was associated with lower cognitive scores (<xref rid="B69" ref-type="bibr">Koch et al., 2019</xref>). A cohort study of 19,887 middle-aged and older U.S. adults with a mean age of 61.8 years in 2020 reported that heavy drinking was associated with risk of dementia. However, drinking 10&#8211;14 drinks per week resulted in better cognitive function (<xref rid="B189" ref-type="bibr">Zhang et al., 2020</xref>). As for wine, it was reported that mild to moderate consumption of wine reduced the risk of cognitive decline, but excessive consumption increased the risk of dementia due to direct neurotoxic effects (<xref rid="B122" ref-type="bibr">Reale et al., 2020</xref>). Based on these results, excessive alcohol consumption (&gt;21 drinks/week) was recognized as a new risk factor for dementia (<xref rid="B81" ref-type="bibr">Livingston et al., 2020</xref>).</p><p>In addition, several recent dose-response meta-analyses have shown that alcohol intake of 27.5 g/day (about two alcoholic beverages) or more is associated with an increased risk of progression to dementia in people with mild cognitive impairment (<xref rid="B74" ref-type="bibr">Lao et al., 2021</xref>), moderate drinking of less than 11 g/day (<xref rid="B121" ref-type="bibr">Ran et al., 2021</xref>) or 12.5 g/day (<xref rid="B173" ref-type="bibr">Xu et al., 2017</xref>) was associated with a reduced risk of dementia, and excessive drinking of 38 g/day or more was associated with an increased risk (<xref rid="B173" ref-type="bibr">Xu et al., 2017</xref>). In a 2023 report from South Korea analyzing 100,292 people with a diagnosis of dementia and 6.3 years of follow-up among 3,933,382 people with a mean age of 55 years, alcohol consumption of 30 g/day or more was also associated with an increased risk of dementia (<xref rid="B55" ref-type="bibr">Jeon et al., 2023</xref>; <xref rid="T1" ref-type="table">Table 1</xref>). Unfortunately, the status of ALDH2 genotyping of these studies is unknown.</p><table-wrap position="float" id="T1" orientation="portrait"><label>TABLE 1</label><caption><p>Relationship between alcohol consumption and risk of dementia.</p></caption><table frame="box" rules="all" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">References</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">Number of subjects</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">Pure alcohol equivalent<break/> (gram/day)</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">Standard drink<break/> (1 drink = 14 gram pure alcohol/day)</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">Risk of dementia</td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">
<xref rid="B121" ref-type="bibr">Ran et al., 2021</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">131777<break/> (meta-analysis of 16 studies)</td><td valign="top" align="center" rowspan="1" colspan="1">11&gt;</td><td valign="top" align="center" rowspan="1" colspan="1">0.8 drink&gt;</td><td valign="top" align="center" rowspan="1" colspan="1">&#8595;</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<xref rid="B173" ref-type="bibr">Xu et al., 2017</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">70150<break/> (meta-analysis of 10 studies)</td><td valign="top" align="center" rowspan="1" colspan="1">12.5&gt;</td><td valign="top" align="center" rowspan="1" colspan="1">0.9 drink&gt;</td><td valign="top" align="center" rowspan="1" colspan="1">&#8595;</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<xref rid="B74" ref-type="bibr">Lao et al., 2021</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">4244<break/> (meta-analysis of 6 studies)</td><td valign="top" align="center" rowspan="1" colspan="1">27.5&lt;</td><td valign="top" align="center" rowspan="1" colspan="1">2.0 drink&lt;</td><td valign="top" align="center" rowspan="1" colspan="1">&#8593;<xref rid="t1fns1" ref-type="table-fn">*</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<xref rid="B55" ref-type="bibr">Jeon et al., 2023</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">3933382<break/> (retrospective cohort study)</td><td valign="top" align="center" rowspan="1" colspan="1">30&lt;</td><td valign="top" align="center" rowspan="1" colspan="1">2.1 drink&lt;</td><td valign="top" align="center" rowspan="1" colspan="1">&#8593;</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<xref rid="B173" ref-type="bibr">Xu et al., 2017</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">70150<break/> (meta-analysis of 10 studies)</td><td valign="top" align="center" rowspan="1" colspan="1">38&lt;</td><td valign="top" align="center" rowspan="1" colspan="1">2.7 drink&lt;</td><td valign="top" align="center" rowspan="1" colspan="1">&#8593;</td></tr></tbody></table><table-wrap-foot><fn><p>&gt;means &#8220;less than.&#8221; &lt;means &#8220;more than.&#8221; Drink equivalents are rounded to the nearest 0.1.</p></fn><fn id="t1fns1"><p>*Increased risk of progression of dementia in patients with mild cognitive impairment.</p></fn></table-wrap-foot></table-wrap><p>In relation to alcohol use disorder (AUD), an analysis of 57,353 early-onset dementia patients in a French population showed that 56.6% were associated with alcohol-related brain damage or AUD (<xref rid="B134" ref-type="bibr">Schwarzinger et al., 2018</xref>). Analyses of 129,182 patients with AUD in the United States (<xref rid="B188" ref-type="bibr">Zhang et al., 2022</xref>) and 13,568 patients with dementia in Western Austria (<xref rid="B193" ref-type="bibr">Zilkens et al., 2014</xref>) similarly showed that AUD is a risk for AD (<xref rid="B188" ref-type="bibr">Zhang et al., 2022</xref>).</p><p>Alcohol consumption is generally considered a modifiable risk factor for dementia, but results in the literature are not entirely consistent (<xref rid="B168" ref-type="bibr">Wiegmann et al., 2020</xref>). The dependence of drinking behavior on sociocultural context and the involvement of health-related factors complicates the analysis for drinking (<xref rid="B81" ref-type="bibr">Livingston et al., 2020</xref>). However, the effects of chronic heavy drinking on brain are clear (<xref rid="B162" ref-type="bibr">Visontay et al., 2021</xref>), demonstrating that excessive drinking causes alcohol-related brain damage.</p></sec><sec id="S10"><title>Effect of alcohol on Alzheimer&#8217;s disease and neurodegeneration</title><p>In support of these epidemiological data, <italic toggle="yes">in vitro</italic> and animal studies also showed alcohol concentration-dependent toxic effects of A&#946; (<xref rid="F3" ref-type="fig">Figure 3A</xref>). Low concentrations of alcohol (0.02&#8211;0.08%) inhibited calcium-sensitive activation of cytosolic phospholipase A2 induced by A&#946; and &#945;-synuclein (related to synaptic damage) (<xref rid="B11" ref-type="bibr">Bate and Williams, 2011</xref>). Low concentrations of alcohol (10 mM), equivalent to low to moderate alcohol drinking disrupted the salt bridge between Asp23 and Lys28, which is required for amyloid dimerization, and inhibited A&#946; formation (<xref rid="B108" ref-type="bibr">Orme&#241;o et al., 2013</xref>). The amyloid pore/channel hypothesis suggests that low concentration of alcohol could inhibit amyloid aggregation, thereby prevented increased calcium concentrations in neurons, and neuronal degeneration, and may explain some of the protective effects from consumption of low amounts of alcoholic beverages (<xref rid="B111" ref-type="bibr">Parodi et al., 2015</xref>). Thus, alcohol consumption at low or moderate concentrations may have a protective effect on A&#946; toxicity to neurons (<xref rid="B11" ref-type="bibr">Bate and Williams, 2011</xref>; <xref rid="B108" ref-type="bibr">Orme&#241;o et al., 2013</xref>; <xref rid="B112" ref-type="bibr">Peng et al., 2020</xref>) (These observations, however, were not made in the context of ALDH2 deficiency.) On the other hand, excessive amounts of alcohol lead to increased BACE1 activity with increased expression of presenilin and nicastrin, which are involved in the production of A&#946;, and APP (<xref rid="B66" ref-type="bibr">Kim et al., 2011</xref>). In addition, excessive amounts of alcohol are also responsible for an increase in total tau due to decreased phosphorylation of proteins associated with the mTOR/AKT pathway (<xref rid="B49" ref-type="bibr">Hoffman et al., 2019</xref>; <xref rid="B58" ref-type="bibr">Kamal et al., 2020</xref>), increased expression of cyclin-dependent kinase 5 (<xref rid="B119" ref-type="bibr">Rajgopal and Vemuri, 2001</xref>) and GSK3&#946; (<xref rid="B49" ref-type="bibr">Hoffman et al., 2019</xref>) that are involved in tau hyperphosphorylation.</p><fig position="float" id="F3" orientation="portrait"><label>FIGURE 3</label><caption><p><bold>(A)</bold> The role of alcohol at different levels of drinking in neurodegeneration. <bold>(B)</bold> Direct and indirect role of excessive alcohol consumption in neurodegeneration. PLA2, phospholipase A2; A&#946;, amyloid &#946;; BACE-1, beta-site amyloid precursor protein cleaving enzyme-1; APP, amyloid precursor protein.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fnagi-15-1223977-g003.jpg"/></fig><p>Excessive alcohol consumption may be involved in the decline of brain functions and accelerated neurodegeneration (<xref rid="B161" ref-type="bibr">Venkataraman et al., 2017</xref>; <xref rid="B75" ref-type="bibr">Le&#243;n et al., 2021</xref>; <xref rid="B120" ref-type="bibr">Ramos et al., 2022</xref>; <xref rid="F3" ref-type="fig">Figure 3B</xref>). Excessive chronic alcohol consumption leads to neuroinflammation and degeneration via impaired mitochondrial energy production/dynamics (<xref rid="B75" ref-type="bibr">Le&#243;n et al., 2021</xref>) and glutamatergic excitotoxicity (<xref rid="B58" ref-type="bibr">Kamal et al., 2020</xref>) as well as microglial activation (<xref rid="B31" ref-type="bibr">Crews et al., 2017</xref>; <xref rid="B161" ref-type="bibr">Venkataraman et al., 2017</xref>; <xref rid="B8" ref-type="bibr">Asatryan et al., 2018</xref>; <xref rid="B120" ref-type="bibr">Ramos et al., 2022</xref>) through Toll-like receptors (TLRs), nod-like receptor family pyrin domain containing 3 inflammasomes, cytokines, and purinergic P2X receptors. Microglial activation leads to elevated peripheral macrophage infiltration, elevated immune mediators, elevated cytokine chemokine release and extracellular vesicles, which are associated with neurodegeneration and synapse loss (<xref rid="B120" ref-type="bibr">Ramos et al., 2022</xref>). TRL4 signaling by alcohol and A&#946; fibril may also play an important role in microglial activation (<xref rid="B161" ref-type="bibr">Venkataraman et al., 2017</xref>). Similar to the involvement of immune cells in lifestyle diseases such as non-alcoholic fatty liver disease (<xref rid="B137" ref-type="bibr">Seike et al., 2020</xref>, <xref rid="B136" ref-type="bibr">2021</xref>), immune abnormalities also play an important role in AD, since alcohol appears to modify the pathogenesis of AD via immune dysfunction (<xref rid="B170" ref-type="bibr">Wu K. M. et al., 2021</xref>). Chronic alcohol consumption induces glutamatergic excitotoxicity by producing elevated glucocorticoid and glutamate concentrations. This glucocorticoid-induced increase in NMDAR and its subunits, NR2A and NR2B, leads to calcium influx into neurons, forming BAX pores on mitochondria, releasing cytochrome c and inducing neuronal cell apoptotic death (<xref rid="B58" ref-type="bibr">Kamal et al., 2020</xref>).</p><p>Alcohol is also involved in indirect neuroinflammation by increasing the expression of inflammatory cytokines, endothelial prostaglandins and inducible nitric oxide synthase, in part through thiamine deficiency, small intestine and liver changes, withdrawal symptoms and traumatic brain injury (<xref rid="B161" ref-type="bibr">Venkataraman et al., 2017</xref>; <xref rid="F3" ref-type="fig">Figure 3B</xref>). Based on these studies, alcohol-induced neuroinflammation may play an important role in the pathogenesis of AD, since alcohol can cause neuroinflammation in AD (<xref rid="B161" ref-type="bibr">Venkataraman et al., 2017</xref>; <xref rid="B75" ref-type="bibr">Le&#243;n et al., 2021</xref>; <xref rid="B34" ref-type="bibr">D&#237;az et al., 2022</xref>; <xref rid="B120" ref-type="bibr">Ramos et al., 2022</xref>).</p></sec><sec id="S11"><title>Effect of alcohol on blood brain barrier</title><p>The blood brain barrier (BBB) is formed by endothelial cells and the pericytes and astrocytes that surround them between the blood and the central nervous system and plays an important role in maintaining homeostasis of brain structure and function (<xref rid="B104" ref-type="bibr">Obermeier et al., 2013</xref>). Various dysfunctions of the BBB in AD are thought to be involved (<xref rid="B147" ref-type="bibr">Sweeney et al., 2018</xref>; <xref rid="B6" ref-type="bibr">Andjelkovic et al., 2023</xref>). The intricate structure of BBB makes it susceptible to dysfunction (<xref rid="B10" ref-type="bibr">Banks, 2016</xref>), and excess alcohol exposure is one of the factors that reduces BBB stability. The presence or absence of BBB dysfunction in the pathogenesis of alcohol and AD is important in considering the effects of peripheral A&#946; on the brain, immune cell infiltration, and involvement of fluid factors in the brain.</p><p>Intraperitoneal (<xref rid="B39" ref-type="bibr">Eisele et al., 2010</xref>) and intravenous (<xref rid="B97" ref-type="bibr">Morales et al., 2020</xref>) administration of A&#946;-containing brain extracts from aged APP Tg mice to young allogeneic mice resulted in deposition of A&#946; in the meninges and brain. And C57BL/6J mice genetically modified to synthesize human A&#946; only in the liver have been reported to have increased plasma and brain A&#946; (<xref rid="B72" ref-type="bibr">Lam et al., 2021</xref>). On the other hand, intraperitoneal administration of <sup>13</sup>C-isotope-labeled brain extracts from mice expressing human A&#946; to APP Tg mice resulted in long-term detection of injected A&#946; in liver and lymphoid tissue but not in brain (<xref rid="B14" ref-type="bibr">Brackhan et al., 2022</xref>). It remains unclear what effect peripheral A&#946; has on A&#946; deposition in the brain. However, it is common to observe in patients with dementia a mixed pathology with multiple brain lesions (<xref rid="B133" ref-type="bibr">Schneider et al., 2007</xref>), and AD patients often experience multiple &#8220;hits&#8221; which are thought to contribute to a more rapid cognitive decline toward dementia (<xref rid="B191" ref-type="bibr">Zhu et al., 2004</xref>; <xref rid="B19" ref-type="bibr">Chakrabarti et al., 2015</xref>). It appears likely that alcohol-induced BBB impairment could be one of these hits, and indeed, chronic alcohol consumption has been reported to directly decrease BBB stability and increase the influx of inflammatory mediators into the brain parenchyma (<xref rid="B144" ref-type="bibr">Singh et al., 2007</xref>; <xref rid="B115" ref-type="bibr">Pimentel et al., 2020</xref>; <xref rid="B120" ref-type="bibr">Ramos et al., 2022</xref>).</p><p>Analysis of postmortem samples from alcoholics without liver cirrhosis or nutritional deficiencies showed that the expressions of the tight junction (TJ) protein, claudin-5, and the basement membrane protein, collagen-IV, were significantly reduced in the dorsolateral prefrontal cortex, resulting in reduced BBB integrity (<xref rid="B128" ref-type="bibr">Rubio-Araiz et al., 2017</xref>). This observation may be related to increased activity of matrix metallopeptidase 9, which is capable of degrading extracellular matrix components and is associated with impaired basement membrane, and impaired angiogenesis (<xref rid="B1" ref-type="bibr">Abdul Muneer et al., 2012</xref>; <xref rid="B128" ref-type="bibr">Rubio-Araiz et al., 2017</xref>). It has also been reported that alcohol-induced downregulation of transient receptor potential melastatin-subfamily member 7 expression caused BBB dysfunction as a result of loss of endothelial cell integrity (<xref rid="B20" ref-type="bibr">Chang et al., 2018</xref>; <xref rid="F4" ref-type="fig">Figure 4A</xref>). <italic toggle="yes">In vitro</italic> studies using primary human brain microvascular endothelial cells also showed that alcohol-induced oxidative stress led to activation of myosin light chain (MLC) kinase, phosphorylation of MLC and TJ proteins, decreased BBB integrity, and accelerated monocyte migration through the BBB (<xref rid="B46" ref-type="bibr">Haorah et al., 2005</xref>).</p><fig position="float" id="F4" orientation="portrait"><label>FIGURE 4</label><caption><p><bold>(A)</bold> Effects of ethanol on the blood-brain barrier. <bold>(B)</bold> The effect of reduced ALDH2 activity on the blood-brain barrier. <bold>(C)</bold> Effects of ethanol and reduced ALDH2 activity on the integrity of the blood brain barrier. Thick lines indicate pathways of exacerbation. MMP-9, matrix metallopeptidase 9; TRPM7, transient receptor potential melastatin-subfamily member 7; ROS, reactive oxygen species; 4-HNE, 4-hydroxynonenal.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fnagi-15-1223977-g004.jpg"/></fig></sec><sec id="S12"><title>Effect of ALDH2 inactivity and alcohol on blood brain barrier</title><p>A role of ALDH2 in BBB integrity has also been suggested. ALDH2 is involved in oxidative and reductive reactions in vascular endothelial cells (<xref rid="B100" ref-type="bibr">Nannelli et al., 2020</xref>) and reduced ALDH2 activity is associated with the acquisition of an early aging phenotype of endothelial cells (<xref rid="B99" ref-type="bibr">Nannelli et al., 2018</xref>), atherosclerosis (<xref rid="B18" ref-type="bibr">Cai et al., 2023</xref>), and coronary artery disease (<xref rid="B172" ref-type="bibr">Xu et al., 2011</xref>; <xref rid="B180" ref-type="bibr">Yasue et al., 2019</xref>). Reduced ALDH2 activity increases 4-HNE-medicated reduction of anti-angiogenesis (<xref rid="B126" ref-type="bibr">Roy and Palaniyandi, 2020</xref>) and migration (<xref rid="B127" ref-type="bibr">Roy et al., 2020</xref>) in mouse coronary endothelial cells and is involved in 4-HNE-induced endothelial dysfunction and mitochondrial dysfunction in human umbilical vein endothelial cells (<xref rid="B99" ref-type="bibr">Nannelli et al., 2018</xref>; <xref rid="F4" ref-type="fig">Figure 4B</xref>).</p><p>Although ethanol has a dose-dependent protective effect against endothelial cell senescence by activating ALDH2, decreased ALDH2 activity in endothelial cells impairs this protection by ethanol (<xref rid="B174" ref-type="bibr">Xue et al., 2018</xref>, <xref rid="B175" ref-type="bibr">2019</xref>). Furthermore, studies using induced pluripotent stem cell-derived endothelial cells demonstrated that even minimal amounts of alcohol impair vascular endothelial function in the presence of ALDH2*2 (<xref rid="B44" ref-type="bibr">Guo et al., 2023</xref>).</p><p>Together, these results indicate that reduced ALDH2 activity leads to endothelial dysfunction, which is exacerbated by ethanol exposure. Although their involvement in the context of AD has not yet been directly determined, endothelial dysfunction due to reduced ALDH2 activity and its exacerbation by ethanol likely contribute to the pathogenesis of AD (<xref rid="F4" ref-type="fig">Figure 4C</xref>).</p></sec><sec id="S13"><title>Role of ALDH2*2 and alcohol in the pathogenesis of AD</title><p>Our laboratory has previously shown that fibroblasts from AD patients with ALDH2*2 mutation or with ApoE &#949;4 allele overexpressing ALDH2*2 exhibit increased aldehydic load, oxidative stress, and mitochondrial dysfunction when compared to fibroblasts from healthy individuals, and that ethanol exposure further aggravated these dysfunctions (<xref rid="B57" ref-type="bibr">Joshi et al., 2019</xref>). Mitochondrial dysfunction, oxidative stress, and elevated brain aldehyde levels were also observed in ethanol-exposed WT mice, but these changes were more pronounced in ALDH2*2/*2 KI mice. The increased aldehydic load in WT mice treated with 1g/kg/day ethanol for 11 weeks and the subsequent aldehydic adducts on mitochondrial proteins results in mitochondrial dysfunction, and the reduced ALDH2 activity in ALDH2*2/*2 KI mice further exacerbates this mechanism by reducing the clearance of toxic aldehydes. We found that chronic ethanol exposure resulted in increased the levels of the AD-related protein A&#946; and neuroinflammation in the brains of ALDH2*2/*2 KI mice compared to WT mice (<xref rid="B57" ref-type="bibr">Joshi et al., 2019</xref>). Importantly, all these pathological processes are reversed by Alda-1 treatment suggested that reduced activity of ALDH2 has a major role in mitochondrial dysfunction and in AD pathology in AD patient-derived cells and in mouse models (<xref rid="B57" ref-type="bibr">Joshi et al., 2019</xref>). These data indicate increased vulnerability of neurons to oxidative stress by alcohol in the presence of inactive, ALDH2*2, enzyme relative to functional ALDH2 and thus suggest that alcohol consumption may exacerbate the pathogenesis of AD patients in carriers of ALDH2*2. Thus, as depicted in <xref rid="F5" ref-type="fig">Figure 5</xref>, we can now link data on the relationship between ALDH2 polymorphisms and AD risk, oxidative stress and AD, aldehydes and AD, alcohol and BBB integrity, and ALDH2 and BBB integrity, as shown in <xref rid="F2" ref-type="fig">Figures 2A</xref>, <xref rid="F3" ref-type="fig">3</xref>, <xref rid="F4" ref-type="fig">4A, B</xref>. Importantly, a more detailed mechanistic hypothesis of the contribution of alcohol consumption to the pathological progression of AD in the reduction of ALDH2 activity emerges (<xref rid="F5" ref-type="fig">Figure 5</xref>). We highlighted the role of 4-HNE accumulation in this mechanism, but recognize that other pathways, yet to be identified, may also contribute to the negative impact of alcohol consumption in patients at risk for AD.</p><fig position="float" id="F5" orientation="portrait"><label>FIGURE 5</label><caption><p>The effect of reduced ALDH2 activity and ethanol on AD pathology. Ethanol appears to affect directly tau homeostasis, increase neuroinflammation and endothelial dysfunction &#8211; all pathologies associated with AD (blue boxes). Ethanol metabolism (purple boxes) results in accumulation of acetaldehyde. Accumulation of acetaldehyde decreases activity of ALDH2 and exacerbates ROS production, lipid peroxidation and accumulation of other toxic aldehydes, such as 4HNE (orange boxes). All these further increase AD-associated pathologies (yellow boxes). Thick lines indicate pathways of exacerbation and dotted lines indicate pathways of attenuation. In humans and in knock-in mice, ALDH2 activity in wild type, ALDH2*1/*1, is 100%; ALDH2 activity in ALDH2*2/*1 (heterozygotes) is 10&#8211;45%; ALDH2 activity in ALDH2*2/*2 (homozygotes) is 2&#8211;5%. Carriers of ALDH2*2/*2 accumulate more aldehydes as indicated by the dotted pathway is the reduced ALDH2 activity. 4-HNE, 4-hydroxynonenal; 4-HNA, 4-hydroxynonenic acid; ROS, reactive oxygen species; PUFAs, polyunsaturated fatty acids; A&#946;, amyloid &#946;.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fnagi-15-1223977-g005.jpg"/></fig><p>Clearly, the effects of alcohol on AD are related to the amount, pattern, frequency and the type of the alcohol consumed, the nutritional status of the individual, and the genotype of the individual (<xref rid="B112" ref-type="bibr">Peng et al., 2020</xref>). A study of AD patients from Taiwan found no relationship between ALDH2 polymorphisms, alcohol consumption, and AD (<xref rid="B171" ref-type="bibr">Wu Y. Y. et al., 2021</xref>). But caution should be exercised in interpreting the results, as the study relied only self-reported alcohol use and made no mention of the amount of alcohol consumed. Since the ALDH2*2 mutation causes a 5-fold increase in acetaldehyde after moderate alcohol drinking compared to wild-type ALDH2 (<xref rid="B182" ref-type="bibr">Yokoyama et al., 2008</xref>), and increased acetaldehyde levels last much longer (<xref rid="B28" ref-type="bibr">Chen et al., 2009</xref>), the effects of ethanol consumption on the human body cannot be ignored, especially in ALDH2*2 individuals. It is likely that this elevated aldehyde toxicity may be a contributor to the pathogenesis of AD. It is therefore important that future large-scale epidemiological studies that include alcohol consumption data should be conducted to clarify the roles of ALDH2 polymorphism and whether a smaller amount of alcohol consumption can contribute to AD in individuals carrying the ALDH2*2 variant.</p><p>Also of interest may be the role of ALDH1A1 in AD, an enzyme involved in alcohol-induced facial flushing, alcohol sensitivity and dependence in Caucasians (<xref rid="B183" ref-type="bibr">Yoshida et al., 1989</xref>; <xref rid="B145" ref-type="bibr">Spence et al., 2003</xref>), and in acetaldehyde detoxification (<xref rid="B88" ref-type="bibr">Marchitti et al., 2008</xref>). Recently, the relationship between ALDH1A1 and AD has been reported (<xref rid="B103" ref-type="bibr">Nikhil et al., 2019</xref>; <xref rid="B79" ref-type="bibr">Li X. et al., 2021</xref>; <xref rid="B151" ref-type="bibr">Tandon et al., 2023</xref>). Both epidemiological studies in AD patients, determining ALDH1A1 genotype and alcohol consumption, and mechanistic studies in mice with such mutations will allow a better assessment of the potential risk of alcohol consumptions for AD development in subjects with ALDH1A1 insufficiency.</p></sec><sec sec-type="conclusion" id="S14"><title>Conclusion</title><p>Epidemiological studies of AD patients and analyses of ALDH<sup>&#8211;/&#8211;</sup> null mice, ALDH2*2 OE Tg mice (<xref rid="F1" ref-type="fig">Figure 1</xref>) and ALDH2*2/*2 KI mice, all suggest that ALDH2 dysfunction may be a risk factor for AD, and that ethanol-induced aldehyde accumulation and its toxicity due to decreased ALDH2 activity may be a factor in AD pathogenesis. Ethanol exposure, which increases mitochondrial dysfunction, neuroinflammation and neurodegeneration and causes BBB disruption, exacerbates AD-like pathology in ALDH2*2/*2 KI mice. Therefore, a detailed large-scale epidemiological evaluation of how alcohol consumption and ALDH2 genotype affect AD and AD progression is needed. Since alcohol consumption is a modifiable lifestyle choice, clear understanding of ALDH2, alcohol consumption and AD onset and progression may help to reduce the number of AD patients, especially in the approximately 8% of the world population with ALDH2*2 polymorphism.</p></sec><sec sec-type="author-contributions" id="S15"><title>Author contributions</title><p>TS: conceptualization, data curation, writing&#8211;original draft preparation, and visualization. TS and C-HC: investigation. C-HC and DM-R: writing&#8211;review and editing. DM-R: project administration. All authors contributed to the article and approved the submitted version.</p></sec></body><back><sec sec-type="COI-statement" id="S17"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="disclaimer" id="S18"><title>Publisher&#8217;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abdul Muneer</surname><given-names>P. M.</given-names></name><name name-style="western"><surname>Alikunju</surname><given-names>S.</given-names></name><name name-style="western"><surname>Szlachetka</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Haorah</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>The mechanisms of cerebral vascular dysfunction and neuroinflammation by MMP-mediated degradation of VEGFR-2 in alcohol ingestion.</article-title><source><italic toggle="yes">Arteriosc. Thromb. Vasc. Biol</italic>.</source><volume>32</volume><fpage>1167</fpage>&#8211;<lpage>1177</lpage>. <pub-id pub-id-type="doi">10.1161/atvbaha.112.247668</pub-id><pub-id pub-id-type="pmid">22402362</pub-id><pub-id pub-id-type="pmcid">PMC3501346</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ai</surname><given-names>L.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>T.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Cui</surname><given-names>D.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Endogenous formaldehyde is a memory-related molecule in mice and humans.</article-title><source><italic toggle="yes">Commun. Biol</italic>.</source><volume>2</volume>:<issue>446</issue>. <pub-id pub-id-type="doi">10.1038/s42003-019-0694-x</pub-id><pub-id pub-id-type="pmid">31815201</pub-id><pub-id pub-id-type="pmcid">PMC6884489</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akhtar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>S. M.</given-names></name><name name-style="western"><surname>Dwivedi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>D.</given-names></name><name name-style="western"><surname>Shaikh</surname><given-names>M. F.</given-names></name><name name-style="western"><surname>Negi</surname><given-names>A.</given-names></name></person-group> (<year>2022</year>). <article-title>Preclinical models for Alzheimer&#8217;s disease: Past, present, and future approaches.</article-title><source><italic toggle="yes">ACS Omega</italic></source><volume>7</volume><fpage>47504</fpage>&#8211;<lpage>47517</lpage>. <pub-id pub-id-type="doi">10.1021/acsomega.2c05609</pub-id><pub-id pub-id-type="pmid">36591205</pub-id><pub-id pub-id-type="pmcid">PMC9798399</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alzheimer</surname><given-names>A.</given-names></name></person-group> (<year>1907</year>). <article-title>Uber eine eigenartige Erkrankung der Hirnrinde.</article-title><source><italic toggle="yes">Zentralbl. Nervenh. Psych.</italic></source><volume>18</volume><fpage>177</fpage>&#8211;<lpage>179</lpage>.</mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amada</surname><given-names>N.</given-names></name><name name-style="western"><surname>Aihara</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ravid</surname><given-names>R.</given-names></name><name name-style="western"><surname>Horie</surname><given-names>M.</given-names></name></person-group> (<year>2005</year>). <article-title>Reduction of NR1 and phosphorylated Ca2+/calmodulin-dependent protein kinase II levels in Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">Neuroreport</italic></source><volume>16</volume><fpage>1809</fpage>&#8211;<lpage>1813</lpage>. <pub-id pub-id-type="doi">10.1097/01.wnr.0000185015.44563.5d</pub-id><pub-id pub-id-type="pmid">16237332</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andjelkovic</surname><given-names>A. V.</given-names></name><name name-style="western"><surname>Situ</surname><given-names>M.</given-names></name><name name-style="western"><surname>Citalan-Madrid</surname><given-names>A. F.</given-names></name><name name-style="western"><surname>Stamatovic</surname><given-names>S. M.</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Keep</surname><given-names>R. F.</given-names></name></person-group> (<year>2023</year>). <article-title>Blood-brain barrier dysfunction in normal aging and neurodegeneration: Mechanisms, impact, and treatments.</article-title><source><italic toggle="yes">Stroke</italic></source><volume>54</volume><fpage>661</fpage>&#8211;<lpage>672</lpage>. <pub-id pub-id-type="doi">10.1161/strokeaha.122.040578</pub-id><pub-id pub-id-type="pmid">36848419</pub-id><pub-id pub-id-type="pmcid">PMC9993074</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anstey</surname><given-names>K. J.</given-names></name><name name-style="western"><surname>Mack</surname><given-names>H. A.</given-names></name><name name-style="western"><surname>Cherbuin</surname><given-names>N.</given-names></name></person-group> (<year>2009</year>). <article-title>Alcohol consumption as a risk factor for dementia and cognitive decline: Meta-analysis of prospective studies.</article-title><source><italic toggle="yes">Am. J. Geriatr. Psychiatry</italic></source><volume>17</volume><fpage>542</fpage>&#8211;<lpage>555</lpage>. <pub-id pub-id-type="doi">10.1097/JGP.0b013e3181a2fd07</pub-id><pub-id pub-id-type="pmid">19546653</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asatryan</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ostrovskaya</surname><given-names>O.</given-names></name><name name-style="western"><surname>Lieu</surname><given-names>D.</given-names></name><name name-style="western"><surname>Davies</surname><given-names>D. L.</given-names></name></person-group> (<year>2018</year>). <article-title>Ethanol differentially modulates P2X4 and P2X7 receptor activity and function in BV2 microglial cells.</article-title><source><italic toggle="yes">Neuropharmacology</italic></source><volume>128</volume><fpage>11</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2017.09.030</pub-id><pub-id pub-id-type="pmid">28943285</pub-id><pub-id pub-id-type="pmcid">PMC6492934</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bai</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mei</surname><given-names>Y.</given-names></name></person-group> (<year>2011</year>). <article-title>Overexpression of aldehyde dehydrogenase-2 attenuates neurotoxicity induced by 4-hydroxynonenal in cultured primary hippocampal neurons.</article-title><source><italic toggle="yes">Neurotox Res</italic>.</source><volume>19</volume><fpage>412</fpage>&#8211;<lpage>422</lpage>. <pub-id pub-id-type="doi">10.1007/s12640-010-9183-1</pub-id><pub-id pub-id-type="pmid">20361289</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Banks</surname><given-names>W. A.</given-names></name></person-group> (<year>2016</year>). <article-title>From blood-brain barrier to blood-brain interface: New opportunities for CNS drug delivery.</article-title><source><italic toggle="yes">Nat. Rev. Drug Discov</italic>.</source><volume>15</volume><fpage>275</fpage>&#8211;<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1038/nrd.2015.21</pub-id><pub-id pub-id-type="pmid">26794270</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bate</surname><given-names>C.</given-names></name><name name-style="western"><surname>Williams</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Ethanol protects cultured neurons against amyloid-&#946; and &#945;-synuclein-induced synapse damage.</article-title><source><italic toggle="yes">Neuropharmacology</italic></source><volume>61</volume><fpage>1406</fpage>&#8211;<lpage>1412</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2011.08.030</pub-id><pub-id pub-id-type="pmid">21903110</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bilkei-Gorzo</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Genetic mouse models of brain ageing and Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">Pharmacol. Ther</italic>.</source><volume>142</volume><fpage>244</fpage>&#8211;<lpage>257</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2013.12.009</pub-id><pub-id pub-id-type="pmid">24362083</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bohr</surname><given-names>V. A.</given-names></name></person-group> (<year>2002</year>). <article-title>Repair of oxidative DNA damage in nuclear and mitochondrial DNA, and some changes with aging in mammalian cells.</article-title><source><italic toggle="yes">Free Radic. Biol. Med</italic>.</source><volume>32</volume><fpage>804</fpage>&#8211;<lpage>812</lpage>. <pub-id pub-id-type="doi">10.1016/s0891-5849(02)00787-6</pub-id><pub-id pub-id-type="pmid">11978482</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brackhan</surname><given-names>M.</given-names></name><name name-style="western"><surname>Calza</surname><given-names>G.</given-names></name><name name-style="western"><surname>Lundgren</surname><given-names>K.</given-names></name><name name-style="western"><surname>Bascu&#241;ana</surname><given-names>P.</given-names></name><name name-style="western"><surname>Br&#252;ning</surname><given-names>T.</given-names></name><name name-style="western"><surname>Soliymani</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Isotope-labeled amyloid-&#946; does not transmit to the brain in a prion-like manner after peripheral administration.</article-title><source><italic toggle="yes">EMBO Rep</italic>.</source><volume>23</volume>:<issue>e54405</issue>. <pub-id pub-id-type="doi">10.15252/embr.202154405</pub-id><pub-id pub-id-type="pmid">35620875</pub-id><pub-id pub-id-type="pmcid">PMC9253763</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brooks</surname><given-names>P. J.</given-names></name><name name-style="western"><surname>Enoch</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Goldman</surname><given-names>D.</given-names></name><name name-style="western"><surname>Li</surname><given-names>T. K.</given-names></name><name name-style="western"><surname>Yokoyama</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>The alcohol flushing response: An unrecognized risk factor for esophageal cancer from alcohol consumption.</article-title><source><italic toggle="yes">PLoS Med</italic>.</source><volume>6</volume>:<issue>e50</issue>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1000050</pub-id><pub-id pub-id-type="pmid">19320537</pub-id><pub-id pub-id-type="pmcid">PMC2659709</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bruce-Keller</surname><given-names>A. J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y. J.</given-names></name><name name-style="western"><surname>Lovell</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Kraemer</surname><given-names>P. J.</given-names></name><name name-style="western"><surname>Gary</surname><given-names>D. S.</given-names></name><name name-style="western"><surname>Brown</surname><given-names>R. R.</given-names></name><etal/></person-group> (<year>1998</year>). <article-title>4-Hydroxynonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rats.</article-title><source><italic toggle="yes">J. Neuropathol. Exp. Neurol</italic>.</source><volume>57</volume><fpage>257</fpage>&#8211;<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1097/00005072-199803000-00007</pub-id><pub-id pub-id-type="pmid">9600218</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Butterfield</surname><given-names>D. A.</given-names></name><name name-style="western"><surname>Reed</surname><given-names>T.</given-names></name><name name-style="western"><surname>Perluigi</surname><given-names>M.</given-names></name><name name-style="western"><surname>De Marco</surname><given-names>C.</given-names></name><name name-style="western"><surname>Coccia</surname><given-names>R.</given-names></name><name name-style="western"><surname>Cini</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment.</article-title><source><italic toggle="yes">Neurosci. Lett</italic>.</source><volume>397</volume><fpage>170</fpage>&#8211;<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2005.12.017</pub-id><pub-id pub-id-type="pmid">16413966</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cai</surname><given-names>N.</given-names></name><name name-style="western"><surname>Li</surname><given-names>C.</given-names></name><name name-style="western"><surname>Gu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>W.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>ALDH2 rs671 and MTHFR rs1801133 polymorphisms are risk factors for arteriosclerosis in multiple arteries.</article-title><source><italic toggle="yes">BMC Cardiovasc. Disord</italic>.</source><volume>23</volume>:<issue>319</issue>. <pub-id pub-id-type="doi">10.1186/s12872-023-03354-0</pub-id><pub-id pub-id-type="pmid">37355582</pub-id><pub-id pub-id-type="pmcid">PMC10290786</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chakrabarti</surname><given-names>S.</given-names></name><name name-style="western"><surname>Khemka</surname><given-names>V. K.</given-names></name><name name-style="western"><surname>Banerjee</surname><given-names>A.</given-names></name><name name-style="western"><surname>Chatterjee</surname><given-names>G.</given-names></name><name name-style="western"><surname>Ganguly</surname><given-names>A.</given-names></name><name name-style="western"><surname>Biswas</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Metabolic risk factors of sporadic Alzheimer&#8217;s disease: Implications in the pathology, pathogenesis and treatment.</article-title><source><italic toggle="yes">Aging Dis</italic>.</source><volume>6</volume><fpage>282</fpage>&#8211;<lpage>299</lpage>. <pub-id pub-id-type="doi">10.14336/ad.2014.002</pub-id><pub-id pub-id-type="pmid">26236550</pub-id><pub-id pub-id-type="pmcid">PMC4509477</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>S. L.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Mao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Mack</surname><given-names>M. L.</given-names></name></person-group> (<year>2018</year>). <article-title>Ethanol&#8217;s effects on transient receptor potential channel expression in brain microvascular endothelial cells.</article-title><source><italic toggle="yes">J. Neuroimmune Pharmacol</italic>.</source><volume>13</volume><fpage>498</fpage>&#8211;<lpage>508</lpage>. <pub-id pub-id-type="doi">10.1007/s11481-018-9796-3</pub-id><pub-id pub-id-type="pmid">29987591</pub-id><pub-id pub-id-type="pmcid">PMC6431236</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>C. C.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>R. B.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y. C.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M. F.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>Y. C.</given-names></name><name name-style="western"><surname>Li</surname><given-names>T. K.</given-names></name><etal/></person-group> (<year>1999</year>). <article-title>Interaction between the functional polymorphisms of the alcohol-metabolism genes in protection against alcoholism.</article-title><source><italic toggle="yes">Am. J. Hum. Genet</italic>.</source><volume>65</volume><fpage>795</fpage>&#8211;<lpage>807</lpage>. <pub-id pub-id-type="doi">10.1086/302540</pub-id><pub-id pub-id-type="pmid">10441588</pub-id><pub-id pub-id-type="pmcid">PMC1377988</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>C. H.</given-names></name><name name-style="western"><surname>Budas</surname><given-names>G. R.</given-names></name><name name-style="western"><surname>Churchill</surname><given-names>E. N.</given-names></name><name name-style="western"><surname>Disatnik</surname><given-names>M. H.</given-names></name><name name-style="western"><surname>Hurley</surname><given-names>T. D.</given-names></name><name name-style="western"><surname>Mochly-Rosen</surname><given-names>D.</given-names></name></person-group> (<year>2008</year>). <article-title>Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart.</article-title><source><italic toggle="yes">Science</italic></source><volume>321</volume><fpage>1493</fpage>&#8211;<lpage>1495</lpage>. <pub-id pub-id-type="doi">10.1126/science.1158554</pub-id><pub-id pub-id-type="pmid">18787169</pub-id><pub-id pub-id-type="pmcid">PMC2741612</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>C. H.</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>J. C. B.</given-names></name><name name-style="western"><surname>Mochly-Rosen</surname><given-names>D.</given-names></name></person-group> (<year>2019</year>). <article-title>ALDH2 and Cardiovascular disease.</article-title><source><italic toggle="yes">Adv. Exp. Med. Biol</italic>.</source><volume>1193</volume><fpage>53</fpage>&#8211;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1007/978-981-13-6260-6_3</pub-id><pub-id pub-id-type="pmid">31368097</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>C. H.</given-names></name><name name-style="western"><surname>Joshi</surname><given-names>A. U.</given-names></name><name name-style="western"><surname>Mochly-Rosen</surname><given-names>D.</given-names></name></person-group> (<year>2016</year>). <article-title>The role of mitochondrial Aldehyde Dehydrogenase 2 (ALDH2) in neuropathology and neurodegeneration.</article-title><source><italic toggle="yes">Acta Neurol. Taiwan</italic></source><volume>25</volume><fpage>111</fpage>&#8211;<lpage>123</lpage>.<pub-id pub-id-type="pmcid">PMC10618051</pub-id><pub-id pub-id-type="pmid">28382610</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>C. H.</given-names></name><name name-style="western"><surname>Kraemer</surname><given-names>B. R.</given-names></name><name name-style="western"><surname>Mochly-Rosen</surname><given-names>D.</given-names></name></person-group> (<year>2022</year>). <article-title>ALDH2 variance in disease and populations.</article-title><source><italic toggle="yes">Dis. Model. Mech</italic>.</source><volume>15</volume>:<issue>dmm049601</issue>. <pub-id pub-id-type="doi">10.1242/dmm.049601</pub-id><pub-id pub-id-type="pmid">35749303</pub-id><pub-id pub-id-type="pmcid">PMC9235878</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>F.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>N.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>X.</given-names></name><name name-style="western"><surname>Qin</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Su</surname><given-names>J.</given-names></name><name name-style="western"><surname>He</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>The potential diagnostic accuracy of urine formaldehyde levels in Alzheimer&#8217;s disease: A systematic review and meta-analysis.</article-title><source><italic toggle="yes">Front. Aging Neurosci</italic>.</source><volume>14</volume>:<issue>1057059</issue>. <pub-id pub-id-type="doi">10.3389/fnagi.2022.1057059</pub-id><pub-id pub-id-type="pmid">36583189</pub-id><pub-id pub-id-type="pmcid">PMC9794019</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>K.</given-names></name><name name-style="western"><surname>Maley</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>P. H.</given-names></name></person-group> (<year>2006</year>). <article-title>Potential inplications of endogenous aldehydes in beta-amyloid misfolding, oligomerization and fibrillogenesis.</article-title><source><italic toggle="yes">J. Neurochem</italic>.</source><volume>99</volume><fpage>1413</fpage>&#8211;<lpage>1424</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2006.04181.x</pub-id><pub-id pub-id-type="pmid">17074066</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y. C.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>G. S.</given-names></name><name name-style="western"><surname>Tsao</surname><given-names>T. P.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M. F.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>R. B.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>S. J.</given-names></name></person-group> (<year>2009</year>). <article-title>Pharmacokinetic and pharmacodynamic basis for overcoming acetaldehyde-induced adverse reaction in Asian alcoholics, heterozygous for the variant ALDH2*2 gene allele.</article-title><source><italic toggle="yes">Pharmacogenet. Genomics</italic></source><volume>19</volume><fpage>588</fpage>&#8211;<lpage>599</lpage>. <pub-id pub-id-type="doi">10.1097/FPC.0b013e32832ecf2e</pub-id><pub-id pub-id-type="pmid">19584771</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clayton</surname><given-names>D. A.</given-names></name><name name-style="western"><surname>Browning</surname><given-names>M. D.</given-names></name></person-group> (<year>2001</year>). <article-title>Deficits in the expression of the NR2B subunit in the hippocampus of aged Fisher 344 rats.</article-title><source><italic toggle="yes">Neurobiol. Aging</italic></source><volume>22</volume><fpage>165</fpage>&#8211;<lpage>168</lpage>. <pub-id pub-id-type="doi">10.1016/s0197-4580(00)00196-2</pub-id><pub-id pub-id-type="pmid">11164294</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clayton</surname><given-names>D. A.</given-names></name><name name-style="western"><surname>Mesches</surname><given-names>M. H.</given-names></name><name name-style="western"><surname>Alvarez</surname><given-names>E.</given-names></name><name name-style="western"><surname>Bickford</surname><given-names>P. C.</given-names></name><name name-style="western"><surname>Browning</surname><given-names>M. D.</given-names></name></person-group> (<year>2002</year>). <article-title>A hippocampal NR2B deficit can mimic age-related changes in long-term potentiation and spatial learning in the Fischer 344 rat.</article-title><source><italic toggle="yes">J. Neurosci</italic>.</source><volume>22</volume><fpage>3628</fpage>&#8211;<lpage>3637</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.22-09-03628.2002</pub-id><pub-id pub-id-type="pmid">11978838</pub-id><pub-id pub-id-type="pmcid">PMC6758397</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crews</surname><given-names>F. T.</given-names></name><name name-style="western"><surname>Lawrimore</surname><given-names>C. J.</given-names></name><name name-style="western"><surname>Walter</surname><given-names>T. J.</given-names></name><name name-style="western"><surname>Coleman</surname><given-names>L. G.</given-names><suffix>Jr.</suffix></name></person-group> (<year>2017</year>). <article-title>The role of neuroimmune signaling in alcoholism.</article-title><source><italic toggle="yes">Neuropharmacology</italic></source><volume>122</volume><fpage>56</fpage>&#8211;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2017.01.031</pub-id><pub-id pub-id-type="pmid">28159648</pub-id><pub-id pub-id-type="pmcid">PMC5493978</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dalleau</surname><given-names>S.</given-names></name><name name-style="western"><surname>Baradat</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gu&#233;raud</surname><given-names>F.</given-names></name><name name-style="western"><surname>Huc</surname><given-names>L.</given-names></name></person-group> (<year>2013</year>). <article-title>Cell death and diseases related to oxidative stress: 4-Hydroxynonenal (HNE) in the balance.</article-title><source><italic toggle="yes">Cell Death Differ</italic>.</source><volume>20</volume><fpage>1615</fpage>&#8211;<lpage>1630</lpage>. <pub-id pub-id-type="doi">10.1038/cdd.2013.138</pub-id><pub-id pub-id-type="pmid">24096871</pub-id><pub-id pub-id-type="pmcid">PMC3824598</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Di Domenico</surname><given-names>F.</given-names></name><name name-style="western"><surname>Tramutola</surname><given-names>A.</given-names></name><name name-style="western"><surname>Butterfield</surname><given-names>D. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of Alzheimer disease and other selected age-related neurodegenerative disorders.</article-title><source><italic toggle="yes">Free Radic. Biol. Med</italic>.</source><volume>111</volume><fpage>253</fpage>&#8211;<lpage>261</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2016.10.490</pub-id><pub-id pub-id-type="pmid">27789292</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>D&#237;az</surname><given-names>G.</given-names></name><name name-style="western"><surname>Lengele</surname><given-names>L.</given-names></name><name name-style="western"><surname>Sourdet</surname><given-names>S.</given-names></name><name name-style="western"><surname>Soriano</surname><given-names>G.</given-names></name><name name-style="western"><surname>de Souto Barreto</surname><given-names>P.</given-names></name></person-group> (<year>2022</year>). <article-title>Nutrients and amyloid &#946; status in the brain: A narrative review.</article-title><source><italic toggle="yes">Ageing Res. Rev</italic>.</source><volume>81</volume>:<issue>101728</issue>. <pub-id pub-id-type="doi">10.1016/j.arr.2022.101728</pub-id><pub-id pub-id-type="pmid">36049590</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dingler</surname><given-names>F. A.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Millington</surname><given-names>C. L.</given-names></name><name name-style="western"><surname>Oberbeck</surname><given-names>N.</given-names></name><name name-style="western"><surname>Watcham</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Two aldehyde clearance systems are essential to prevent lethal formaldehyde accumulation in mice and humans.</article-title><source><italic toggle="yes">Mol. Cell</italic>.</source><volume>80</volume><fpage>996</fpage>&#8211;<lpage>1012.e9</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2020.10.012</pub-id><pub-id pub-id-type="pmid">33147438</pub-id><pub-id pub-id-type="pmcid">PMC7758861</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Drake</surname><given-names>J.</given-names></name><name name-style="western"><surname>Petroze</surname><given-names>R.</given-names></name><name name-style="western"><surname>Castegna</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Keller</surname><given-names>J. N.</given-names></name><name name-style="western"><surname>Markesbery</surname><given-names>W. R.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>4-Hydroxynonenal oxidatively modifies histones: Implications for Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">Neurosci. Lett</italic>.</source><volume>356</volume><fpage>155</fpage>&#8211;<lpage>158</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2003.11.047</pub-id><pub-id pub-id-type="pmid">15036618</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>D&#8217;Souza</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Elharram</surname><given-names>A.</given-names></name><name name-style="western"><surname>Soon-Shiong</surname><given-names>R.</given-names></name><name name-style="western"><surname>Andrew</surname><given-names>R. D.</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>B. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Characterization of Aldh2 (-/-) mice as an age-related model of cognitive impairment and Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">Mol. Brain</italic></source><volume>8</volume>:<issue>27</issue>. <pub-id pub-id-type="doi">10.1186/s13041-015-0117-y</pub-id><pub-id pub-id-type="pmid">25910195</pub-id><pub-id pub-id-type="pmcid">PMC4409701</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Edenberg</surname><given-names>H. J.</given-names></name><name name-style="western"><surname>Foroud</surname><given-names>T.</given-names></name></person-group> (<year>2013</year>). <article-title>Genetics and alcoholism.</article-title><source><italic toggle="yes">Nat. Rev. Gastroenterol. Hepatol</italic>.</source><volume>10</volume><fpage>487</fpage>&#8211;<lpage>494</lpage>. <pub-id pub-id-type="doi">10.1038/nrgastro.2013.86</pub-id><pub-id pub-id-type="pmid">23712313</pub-id><pub-id pub-id-type="pmcid">PMC4056340</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eisele</surname><given-names>Y. S.</given-names></name><name name-style="western"><surname>Oberm&#252;ller</surname><given-names>U.</given-names></name><name name-style="western"><surname>Heilbronner</surname><given-names>G.</given-names></name><name name-style="western"><surname>Baumann</surname><given-names>F.</given-names></name><name name-style="western"><surname>Kaeser</surname><given-names>S. A.</given-names></name><name name-style="western"><surname>Wolburg</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis.</article-title><source><italic toggle="yes">Science</italic></source><volume>330</volume><fpage>980</fpage>&#8211;<lpage>982</lpage>. <pub-id pub-id-type="doi">10.1126/science.1194516</pub-id><pub-id pub-id-type="pmid">20966215</pub-id><pub-id pub-id-type="pmcid">PMC3233904</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elyaman</surname><given-names>W.</given-names></name><name name-style="western"><surname>Yardin</surname><given-names>C.</given-names></name><name name-style="western"><surname>Hugon</surname><given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>Involvement of glycogen synthase kinase-3beta and tau phosphorylation in neuronal Golgi disassembly.</article-title><source><italic toggle="yes">J. Neurochem</italic>.</source><volume>81</volume><fpage>870</fpage>&#8211;<lpage>880</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.2002.00838.x</pub-id><pub-id pub-id-type="pmid">12065646</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fukuda</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kanou</surname><given-names>F.</given-names></name><name name-style="western"><surname>Shimada</surname><given-names>N.</given-names></name><name name-style="western"><surname>Sawabe</surname><given-names>M.</given-names></name><name name-style="western"><surname>Saito</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Murayama</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Elevated levels of 4-hydroxynonenal-histidine Michael adduct in the hippocampi of patients with Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">Biomed. Res</italic>.</source><volume>30</volume><fpage>227</fpage>&#8211;<lpage>233</lpage>. <pub-id pub-id-type="doi">10.2220/biomedres.30.227</pub-id><pub-id pub-id-type="pmid">19729853</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gri&#241;an-Ferr&#233;</surname><given-names>C.</given-names></name><name name-style="western"><surname>Palomera-&#193;valos</surname><given-names>V.</given-names></name><name name-style="western"><surname>Puigoriol-Illamola</surname><given-names>D.</given-names></name><name name-style="western"><surname>Camins</surname><given-names>A.</given-names></name><name name-style="western"><surname>Porquet</surname><given-names>D.</given-names></name><name name-style="western"><surname>Pl&#225;</surname><given-names>V.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Behaviour and cognitive changes correlated with hippocampal neuroinflammaging and neuronal markers in female SAMP8, a model of accelerated senescence.</article-title><source><italic toggle="yes">Exp. Gerontol</italic>.</source><volume>80</volume><fpage>57</fpage>&#8211;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1016/j.exger.2016.03.014</pub-id><pub-id pub-id-type="pmid">27094468</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gri&#241;&#225;n-Ferr&#233;</surname><given-names>C.</given-names></name><name name-style="western"><surname>Sarroca</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ivanova</surname><given-names>A.</given-names></name><name name-style="western"><surname>Puigoriol-Illamola</surname><given-names>D.</given-names></name><name name-style="western"><surname>Aguado</surname><given-names>F.</given-names></name><name name-style="western"><surname>Camins</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Epigenetic mechanisms underlying cognitive impairment and Alzheimer disease hallmarks in 5XFAD mice.</article-title><source><italic toggle="yes">Aging</italic></source><volume>8</volume><fpage>664</fpage>&#8211;<lpage>684</lpage>. <pub-id pub-id-type="doi">10.18632/aging.100906</pub-id><pub-id pub-id-type="pmid">27013617</pub-id><pub-id pub-id-type="pmcid">PMC4925821</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Paik</surname><given-names>D. T.</given-names></name><name name-style="western"><surname>Justesen</surname><given-names>J. M.</given-names></name><name name-style="western"><surname>Chandy</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>SGLT2 inhibitor ameliorates endothelial dysfunction associated with the common ALDH2 alcohol flushing variant.</article-title><source><italic toggle="yes">Sci. Transl. Med</italic>.</source><volume>15</volume>:<issue>eab9952</issue>. <pub-id pub-id-type="doi">10.1126/scitranslmed.abp9952</pub-id><pub-id pub-id-type="pmid">36696485</pub-id><pub-id pub-id-type="pmcid">PMC10297796</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gwon</surname><given-names>A. R.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J. S.</given-names></name><name name-style="western"><surname>Arumugam</surname><given-names>T. V.</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>Y. K.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>S. L.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S. H.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Oxidative lipid modification of nicastrin enhances amyloidogenic &#947;-secretase activity in Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">Aging Cell</italic></source><volume>11</volume><fpage>559</fpage>&#8211;<lpage>568</lpage>. <pub-id pub-id-type="doi">10.1111/j.1474-9726.2012.00817.x</pub-id><pub-id pub-id-type="pmid">22404891</pub-id><pub-id pub-id-type="pmcid">PMC4217088</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haorah</surname><given-names>J.</given-names></name><name name-style="western"><surname>Knipe</surname><given-names>B.</given-names></name><name name-style="western"><surname>Leibhart</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ghorpade</surname><given-names>A.</given-names></name><name name-style="western"><surname>Persidsky</surname><given-names>Y.</given-names></name></person-group> (<year>2005</year>). <article-title>Alcohol-induced oxidative stress in brain endothelial cells causes blood-brain barrier dysfunction.</article-title><source><italic toggle="yes">J. Leukoc Biol</italic>.</source><volume>78</volume><fpage>1223</fpage>&#8211;<lpage>1232</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.0605340</pub-id><pub-id pub-id-type="pmid">16204625</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>R.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Miao</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>Formaldehyde stress.</article-title><source><italic toggle="yes">Sci. China Life Sci</italic>.</source><volume>53</volume><fpage>1399</fpage>&#8211;<lpage>1404</lpage>. <pub-id pub-id-type="doi">10.1007/s11427-010-4112-3</pub-id><pub-id pub-id-type="pmid">21181340</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hebert</surname><given-names>L. E.</given-names></name><name name-style="western"><surname>Weuve</surname><given-names>J.</given-names></name><name name-style="western"><surname>Scherr</surname><given-names>P. A.</given-names></name><name name-style="western"><surname>Evans</surname><given-names>D. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Alzheimer disease in the United States (2010-2050) estimated using the 2010 census.</article-title><source><italic toggle="yes">Neurology</italic></source><volume>80</volume><fpage>1778</fpage>&#8211;<lpage>1783</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e31828726f5</pub-id><pub-id pub-id-type="pmid">23390181</pub-id><pub-id pub-id-type="pmcid">PMC3719424</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoffman</surname><given-names>J. L.</given-names></name><name name-style="western"><surname>Faccidomo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>M.</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>S. M.</given-names></name><name name-style="western"><surname>Agoglia</surname><given-names>A. E.</given-names></name><name name-style="western"><surname>May</surname><given-names>A. M.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Alcohol drinking exacerbates neural and behavioral pathology in the 3xTg-AD mouse model of Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">Int Rev. Neurobiol</italic>.</source><volume>148</volume><fpage>169</fpage>&#8211;<lpage>230</lpage>. <pub-id pub-id-type="doi">10.1016/bs.irn.2019.10.017</pub-id><pub-id pub-id-type="pmid">31733664</pub-id><pub-id pub-id-type="pmcid">PMC6939615</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Teng</surname><given-names>W.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hao</surname><given-names>F.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>N.</given-names></name></person-group> (<year>2016</year>). <article-title>Homocysteine and Alzheimer&#8217;s disease: Evidence for a causal link from mendelian randomization.</article-title><source><italic toggle="yes">J. Alzheimers Dis</italic>.</source><volume>52</volume><fpage>747</fpage>&#8211;<lpage>756</lpage>. <pub-id pub-id-type="doi">10.3233/jad-150977</pub-id><pub-id pub-id-type="pmid">27031476</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kozekov</surname><given-names>I. D.</given-names></name><name name-style="western"><surname>Kozekova</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Lloyd</surname><given-names>R. S.</given-names></name><name name-style="western"><surname>Rizzo</surname><given-names>C. J.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>DNA cross-link induced by trans-4-hydroxynonenal.</article-title><source><italic toggle="yes">Environ. Mol. Mutagen</italic>.</source><volume>51</volume><fpage>625</fpage>&#8211;<lpage>634</lpage>. <pub-id pub-id-type="doi">10.1002/em.20599</pub-id><pub-id pub-id-type="pmid">20577992</pub-id><pub-id pub-id-type="pmcid">PMC3140422</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>M. C.</given-names></name><name name-style="western"><surname>Tu</surname><given-names>H. Y.</given-names></name><name name-style="western"><surname>Chung</surname><given-names>R. H.</given-names></name><name name-style="western"><surname>Kuo</surname><given-names>H. W.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>T. H.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C. H.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Changes of neurofilament light chain in patients with alcohol dependence following withdrawal and the genetic effect from ALDH2 Polymorphism.</article-title><source><italic toggle="yes">Eur. Arch. Psychiatry Clin. Neurosci</italic>.</source><pub-id pub-id-type="doi">10.1007/s00406-023-01635-5</pub-id><comment>[Epub ahead of print]</comment>.<pub-id pub-id-type="pmid">37314537</pub-id><pub-id pub-id-type="pmcid">PMC10719424</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hynd</surname><given-names>M. R.</given-names></name><name name-style="western"><surname>Scott</surname><given-names>H. L.</given-names></name><name name-style="western"><surname>Dodd</surname><given-names>P. R.</given-names></name></person-group> (<year>2004</year>). <article-title>Differential expression of N-methyl-D-aspartate receptor NR2 isoforms in Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">J. Neurochem</italic>.</source><volume>90</volume><fpage>913</fpage>&#8211;<lpage>919</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2004.02548.x</pub-id><pub-id pub-id-type="pmid">15287897</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ilomaki</surname><given-names>J.</given-names></name><name name-style="western"><surname>Jokanovic</surname><given-names>N.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>E. C.</given-names></name><name name-style="western"><surname>Lonnroos</surname><given-names>E.</given-names></name></person-group> (<year>2015</year>). <article-title>Alcohol consumption, dementia and cognitive decline: An overview of systematic reviews.</article-title><source><italic toggle="yes">Curr. Clin. Pharmacol</italic>.</source><volume>10</volume><fpage>204</fpage>&#8211;<lpage>212</lpage>. <pub-id pub-id-type="doi">10.2174/157488471003150820145539</pub-id><pub-id pub-id-type="pmid">26338173</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jeon</surname><given-names>K. H.</given-names></name><name name-style="western"><surname>Han</surname><given-names>K.</given-names></name><name name-style="western"><surname>Jeong</surname><given-names>S. M.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yoo</surname><given-names>J. E.</given-names></name><name name-style="western"><surname>Yoo</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Changes in alcohol consumption and risk of dementia in a nationwide cohort in South Korea.</article-title><source><italic toggle="yes">JAMA Netw. Open</italic></source><volume>6</volume>:<issue>e2254771</issue>. <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2022.54771</pub-id><pub-id pub-id-type="pmid">36745453</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>X.</given-names></name><name name-style="western"><surname>Long</surname><given-names>T.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Associations of alcohol dehydrogenase and aldehyde dehydrogenase polymorphism with cognitive impairment among the oldest-old in China.</article-title><source><italic toggle="yes">Front. Aging Neurosci</italic>.</source><volume>13</volume>:<issue>710966</issue>. <pub-id pub-id-type="doi">10.3389/fnagi.2021.710966</pub-id><pub-id pub-id-type="pmid">35368830</pub-id><pub-id pub-id-type="pmcid">PMC8965653</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Joshi</surname><given-names>A. U.</given-names></name><name name-style="western"><surname>Van Wassenhove</surname><given-names>L. D.</given-names></name><name name-style="western"><surname>Logas</surname><given-names>K. R.</given-names></name><name name-style="western"><surname>Minhas</surname><given-names>P. S.</given-names></name><name name-style="western"><surname>Andreasson</surname><given-names>K. I.</given-names></name><name name-style="western"><surname>Weinberg</surname><given-names>K. I.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Aldehyde dehydrogenase 2 activity and aldehydic load contribute to neuroinflammation and Alzheimer&#8217;s disease related pathology.</article-title><source><italic toggle="yes">Acta Neuropathol. Commun</italic>.</source><volume>7</volume>:<issue>190</issue>. <pub-id pub-id-type="doi">10.1186/s40478-019-0839-7</pub-id><pub-id pub-id-type="pmid">31829281</pub-id><pub-id pub-id-type="pmcid">PMC6907112</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamal</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>G. C.</given-names></name><name name-style="western"><surname>Ibrahim</surname><given-names>S. F.</given-names></name><name name-style="western"><surname>Shaikh</surname><given-names>M. F.</given-names></name><name name-style="western"><surname>Mohamed</surname><given-names>I. N.</given-names></name><name name-style="western"><surname>Mohamed</surname><given-names>R. M. P.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Alcohol use disorder, neurodegeneration, Alzheimer&#8217;s and Parkinson&#8217;s Disease: Interplay between oxidative stress, neuroimmune response and excitotoxicity.</article-title><source><italic toggle="yes">Front. Cell Neurosci</italic>.</source><volume>14</volume>:<issue>282</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2020.00282</pub-id><pub-id pub-id-type="pmid">33061892</pub-id><pub-id pub-id-type="pmcid">PMC7488355</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamino</surname><given-names>K.</given-names></name><name name-style="western"><surname>Nagasaka</surname><given-names>K.</given-names></name><name name-style="western"><surname>Imagawa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yoneda</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ueki</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2000</year>). <article-title>Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer&#8217;s disease in the Japanese population.</article-title><source><italic toggle="yes">Biochem. Biophys. Res. Commun</italic>.</source><volume>273</volume><fpage>192</fpage>&#8211;<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1006/bbrc.2000.2923</pub-id><pub-id pub-id-type="pmid">10873585</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanamaru</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kamimura</surname><given-names>N.</given-names></name><name name-style="western"><surname>Yokota</surname><given-names>T.</given-names></name><name name-style="western"><surname>Iuchi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Nishimaki</surname><given-names>K.</given-names></name><name name-style="western"><surname>Takami</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Oxidative stress accelerates amyloid deposition and memory impairment in a double-transgenic mouse model of Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">Neurosci. Lett</italic>.</source><volume>587</volume><fpage>126</fpage>&#8211;<lpage>131</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2014.12.033</pub-id><pub-id pub-id-type="pmid">25529196</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kawarabayashi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Younkin</surname><given-names>L. H.</given-names></name><name name-style="western"><surname>Saido</surname><given-names>T. C.</given-names></name><name name-style="western"><surname>Shoji</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ashe</surname><given-names>K. H.</given-names></name><name name-style="western"><surname>Younkin</surname><given-names>S. G.</given-names></name></person-group> (<year>2001</year>). <article-title>Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">J. Neurosci</italic>.</source><volume>21</volume><fpage>372</fpage>&#8211;<lpage>381</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.21-02-00372.2001</pub-id><pub-id pub-id-type="pmid">11160418</pub-id><pub-id pub-id-type="pmcid">PMC6763819</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Keller</surname><given-names>J. N.</given-names></name><name name-style="western"><surname>Pang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Geddes</surname><given-names>J. W.</given-names></name><name name-style="western"><surname>Begley</surname><given-names>J. G.</given-names></name><name name-style="western"><surname>Germeyer</surname><given-names>A.</given-names></name><name name-style="western"><surname>Waeg</surname><given-names>G.</given-names></name><etal/></person-group> (<year>1997</year>). <article-title>Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: Role of the lipid peroxidation product 4-hydroxynonenal.</article-title><source><italic toggle="yes">J. Neurochem</italic>.</source><volume>69</volume><fpage>273</fpage>&#8211;<lpage>284</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.1997.69010273.x</pub-id><pub-id pub-id-type="pmid">9202320</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Keller</surname><given-names>J. N.</given-names></name><name name-style="western"><surname>Schmitt</surname><given-names>F. A.</given-names></name><name name-style="western"><surname>Scheff</surname><given-names>S. W.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Butterfield</surname><given-names>D. A.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Evidence of increased oxidative damage in subjects with mild cognitive impairment.</article-title><source><italic toggle="yes">Neurology</italic></source><volume>64</volume><fpage>1152</fpage>&#8211;<lpage>1156</lpage>. <pub-id pub-id-type="doi">10.1212/01.Wnl.0000156156.13641.Ba</pub-id><pub-id pub-id-type="pmid">15824339</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Barve</surname><given-names>K. H.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>M. S.</given-names></name></person-group> (<year>2020</year>). <article-title>Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">Curr. Neuropharmacol</italic>.</source><volume>18</volume><fpage>1106</fpage>&#8211;<lpage>1125</lpage>. <pub-id pub-id-type="doi">10.2174/1570159x18666200528142429</pub-id><pub-id pub-id-type="pmid">32484110</pub-id><pub-id pub-id-type="pmcid">PMC7709159</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>J. M.</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>R.</given-names></name><name name-style="western"><surname>Shin</surname><given-names>I. S.</given-names></name><name name-style="western"><surname>Jung</surname><given-names>J. S.</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>J. S.</given-names></name></person-group> (<year>2004</year>). <article-title>Assessment of association between mitochondrial aldehyde dehydrogenase polymorphism and Alzheimer&#8217;s disease in an older Korean population.</article-title><source><italic toggle="yes">Neurobiol. Aging</italic></source><volume>25</volume><fpage>295</fpage>&#8211;<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1016/s0197-4580(03)00114-3</pub-id><pub-id pub-id-type="pmid">15123334</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>S. R.</given-names></name><name name-style="western"><surname>Jeong</surname><given-names>H. Y.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>S. P.</given-names></name><name name-style="western"><surname>Seo</surname><given-names>M. Y.</given-names></name><name name-style="western"><surname>Yun</surname><given-names>Y. K.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Effects of chronic alcohol consumption on expression levels of APP and A&#946;-producing enzymes.</article-title><source><italic toggle="yes">BMB Rep</italic>.</source><volume>44</volume><fpage>135</fpage>&#8211;<lpage>139</lpage>. <pub-id pub-id-type="doi">10.5483/BMBRep.2011.44.2.135</pub-id><pub-id pub-id-type="pmid">21345314</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klyosov</surname><given-names>A. A.</given-names></name><name name-style="western"><surname>Rashkovetsky</surname><given-names>L. G.</given-names></name><name name-style="western"><surname>Tahir</surname><given-names>M. K.</given-names></name><name name-style="western"><surname>Keung</surname><given-names>W. M.</given-names></name></person-group> (<year>1996</year>). <article-title>Possible role of liver cytosolic and mitochondrial aldehyde dehydrogenases in acetaldehyde metabolism.</article-title><source><italic toggle="yes">Biochemistry</italic></source><volume>35</volume><fpage>4445</fpage>&#8211;<lpage>4456</lpage>. <pub-id pub-id-type="doi">10.1021/bi9521093</pub-id><pub-id pub-id-type="pmid">8605194</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knopp</surname><given-names>R. C.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S. H.</given-names></name><name name-style="western"><surname>Hollas</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nepomuceno</surname><given-names>E.</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>D.</given-names></name><name name-style="western"><surname>Tam</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Interaction of oxidative stress and neurotrauma in ALDH2(-/-) mice causes significant and persistent behavioral and pro-inflammatory effects in a tractable model of mild traumatic brain injury.</article-title><source><italic toggle="yes">Redox Biol</italic>.</source><volume>32</volume>:<issue>101486</issue>. <pub-id pub-id-type="doi">10.1016/j.redox.2020.101486</pub-id><pub-id pub-id-type="pmid">32155582</pub-id><pub-id pub-id-type="pmcid">PMC7063127</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koch</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fitzpatrick</surname><given-names>A. L.</given-names></name><name name-style="western"><surname>Rapp</surname><given-names>S. R.</given-names></name><name name-style="western"><surname>Nahin</surname><given-names>R. L.</given-names></name><name name-style="western"><surname>Williamson</surname><given-names>J. D.</given-names></name><name name-style="western"><surname>Lopez</surname><given-names>O. L.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Alcohol consumption and risk of dementia and cognitive decline among older adults with or without mild cognitive impairment.</article-title><source><italic toggle="yes">JAMA Netw. Open</italic></source><volume>2</volume>:<issue>e1910319</issue>. <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2019.10319</pub-id><pub-id pub-id-type="pmid">31560382</pub-id><pub-id pub-id-type="pmcid">PMC6777245</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Komatsu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Shibata</surname><given-names>N.</given-names></name><name name-style="western"><surname>Ohnuma</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kuerban</surname><given-names>B.</given-names></name><name name-style="western"><surname>Tomson</surname><given-names>K.</given-names></name><name name-style="western"><surname>Toda</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Polymorphisms in the aldehyde dehydrogenase 2 and dopamine &#946; hydroxylase genes are not associated with Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">J. Neural Transm.</italic></source><volume>121</volume><fpage>427</fpage>&#8211;<lpage>432</lpage>. <pub-id pub-id-type="doi">10.1007/s00702-013-1112-z</pub-id><pub-id pub-id-type="pmid">24201835</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kou</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>H.</given-names></name><name name-style="western"><surname>Cui</surname><given-names>D.</given-names></name><name name-style="western"><surname>Han</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tong</surname><given-names>Z.</given-names></name></person-group> (<year>2022</year>). <article-title>Formaldehyde toxicity in age-related neurological dementia.</article-title><source><italic toggle="yes">Ageing Res. Rev</italic>.</source><volume>73</volume>:<issue>101512</issue>. <pub-id pub-id-type="doi">10.1016/j.arr.2021.101512</pub-id><pub-id pub-id-type="pmid">34798299</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lam</surname><given-names>V.</given-names></name><name name-style="western"><surname>Takechi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Hackett</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Francis</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bynevelt</surname><given-names>M.</given-names></name><name name-style="western"><surname>Celliers</surname><given-names>L. M.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Synthesis of human amyloid restricted to liver results in an Alzheimer disease-like neurodegenerative phenotype.</article-title><source><italic toggle="yes">PLoS Biol</italic>.</source><volume>19</volume>:<issue>e3001358</issue>. <pub-id pub-id-type="doi">10.1371/journal.pbio.3001358</pub-id><pub-id pub-id-type="pmid">34520451</pub-id><pub-id pub-id-type="pmcid">PMC8439475</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lane</surname><given-names>C. A.</given-names></name><name name-style="western"><surname>Hardy</surname><given-names>J.</given-names></name><name name-style="western"><surname>Schott</surname><given-names>J. M.</given-names></name></person-group> (<year>2018</year>). <article-title>Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">Eur. J. Neurol</italic>.</source><volume>25</volume><fpage>59</fpage>&#8211;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1111/ene.13439</pub-id><pub-id pub-id-type="pmid">28872215</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hou</surname><given-names>L.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hui</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>P.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>K.</given-names></name></person-group> (<year>2021</year>). <article-title>Association between alcohol intake, mild cognitive impairment and progression to dementia: A dose-response meta-analysis.</article-title><source><italic toggle="yes">Aging Clin. Exp. Res</italic>.</source><volume>33</volume><fpage>1175</fpage>&#8211;<lpage>1185</lpage>. <pub-id pub-id-type="doi">10.1007/s40520-020-01605-0</pub-id><pub-id pub-id-type="pmid">32488474</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Le&#243;n</surname><given-names>B. E.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Franca-Solomon</surname><given-names>G.</given-names></name><name name-style="western"><surname>Shang</surname><given-names>P.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>D. S.</given-names></name></person-group> (<year>2021</year>). <article-title>Alcohol-induced neuroinflammatory response and mitochondrial dysfunction on aging and Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">Front. Behav. Neurosci</italic>.</source><volume>15</volume>:<issue>778456</issue>. <pub-id pub-id-type="doi">10.3389/fnbeh.2021.778456</pub-id><pub-id pub-id-type="pmid">35221939</pub-id><pub-id pub-id-type="pmcid">PMC8866940</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>M. H.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>J. P.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C. Y.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>H. J.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Disturbance of endogenous hydrogen sulfide generation and endoplasmic reticulum stress in hippocampus are involved in homocysteine-induced defect in learning and memory of rats.</article-title><source><italic toggle="yes">Behav. Brain Res</italic>.</source><volume>262</volume><fpage>35</fpage>&#8211;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2014.01.001</pub-id><pub-id pub-id-type="pmid">24423987</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>H. J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>M. H.</given-names></name><name name-style="western"><surname>Zou</surname><given-names>W.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Hydrogen sulfide ameliorates homocysteine-induced cognitive dysfunction by inhibition of reactive aldehydes involving upregulation of ALDH2.</article-title><source><italic toggle="yes">Int. J. Neuropsychopharmacol</italic>.</source><volume>20</volume><fpage>305</fpage>&#8211;<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1093/ijnp/pyw103</pub-id><pub-id pub-id-type="pmid">27988490</pub-id><pub-id pub-id-type="pmcid">PMC5409037</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Qu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mou</surname><given-names>L.</given-names></name><name name-style="western"><surname>Miao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Xi</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Formaldehyde and De/Methylation in age-related cognitive impairment.</article-title><source><italic toggle="yes">Genes</italic></source><volume>12</volume>:<issue>913</issue>. <pub-id pub-id-type="doi">10.3390/genes12060913</pub-id><pub-id pub-id-type="pmid">34199279</pub-id><pub-id pub-id-type="pmcid">PMC8231798</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Jing</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>T.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>Q.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Synaptic dysfunction of Aldh1a1 neurons in the ventral tegmental area causes impulsive behaviors.</article-title><source><italic toggle="yes">Mol. Neurodegener</italic>.</source><volume>16</volume>:<issue>73</issue>. <pub-id pub-id-type="doi">10.1186/s13024-021-00494-9</pub-id><pub-id pub-id-type="pmid">34702328</pub-id><pub-id pub-id-type="pmcid">PMC8549305</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Komatsu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Murray</surname><given-names>I. V.</given-names></name><name name-style="western"><surname>Axelsen</surname><given-names>P. H.</given-names></name></person-group> (<year>2008</year>). <article-title>Promotion of amyloid beta protein misfolding and fibrillogenesis by a lipid oxidation product.</article-title><source><italic toggle="yes">J. Mol. Biol</italic>.</source><volume>377</volume><fpage>1236</fpage>&#8211;<lpage>1250</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2008.01.057</pub-id><pub-id pub-id-type="pmid">18304576</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Livingston</surname><given-names>G.</given-names></name><name name-style="western"><surname>Huntley</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sommerlad</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ames</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ballard</surname><given-names>C.</given-names></name><name name-style="western"><surname>Banerjee</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.</article-title><source><italic toggle="yes">Lancet</italic></source><volume>396</volume><fpage>413</fpage>&#8211;<lpage>446</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(20)30367-6</pub-id><pub-id pub-id-type="pmid">32738937</pub-id><pub-id pub-id-type="pmcid">PMC7392084</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lok</surname><given-names>K.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>H.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Characterization of the APP/PS1 mouse model of Alzheimer&#8217;s disease in senescence accelerated background.</article-title><source><italic toggle="yes">Neurosci. Lett</italic>.</source><volume>557(Pt. B)</volume><fpage>84</fpage>&#8211;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2013.10.051</pub-id><pub-id pub-id-type="pmid">24176881</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lovell</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Ehmann</surname><given-names>W. D.</given-names></name><name name-style="western"><surname>Mattson</surname><given-names>M. P.</given-names></name><name name-style="western"><surname>Markesbery</surname><given-names>W. R.</given-names></name></person-group> (<year>1997</year>). <article-title>Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">Neurobiol. Aging</italic></source><volume>18</volume><fpage>457</fpage>&#8211;<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1016/s0197-4580(97)00108-5</pub-id><pub-id pub-id-type="pmid">9390770</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Miao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Su</surname><given-names>T.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>He</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Formaldehyde induces hyperphosphorylation and polymerization of Tau protein both in vitro and in vivo.</article-title><source><italic toggle="yes">Biochim. Biophys. Acta</italic></source><volume>1830</volume><fpage>4102</fpage>&#8211;<lpage>4116</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbagen.2013.04.028</pub-id><pub-id pub-id-type="pmid">23628704</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S. H.</given-names></name><name name-style="western"><surname>VandeVrede</surname><given-names>L.</given-names></name><name name-style="western"><surname>Qin</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Ben Aissa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Larson</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">Mol. Neurodegener</italic>.</source><volume>11</volume>:<issue>35</issue>. <pub-id pub-id-type="doi">10.1186/s13024-016-0103-6</pub-id><pub-id pub-id-type="pmid">27129593</pub-id><pub-id pub-id-type="pmcid">PMC4850651</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>L.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Z. N.</given-names></name></person-group> (<year>2016</year>). <article-title>Role of ADH1B rs1229984 and ALDH2 rs671 gene polymorphisms in the development of Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">Genet. Mol. Res</italic>.</source><volume>15</volume>. <pub-id pub-id-type="doi">10.4238/gmr.15048740</pub-id><pub-id pub-id-type="pmid">27808372</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manthey</surname><given-names>J.</given-names></name><name name-style="western"><surname>Shield</surname><given-names>K. D.</given-names></name><name name-style="western"><surname>Rylett</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hasan</surname><given-names>O. S. M.</given-names></name><name name-style="western"><surname>Probst</surname><given-names>C.</given-names></name><name name-style="western"><surname>Rehm</surname><given-names>J.</given-names></name></person-group> (<year>2019</year>). <article-title>Global alcohol exposure between 1990 and 2017 and forecasts until 2030: A modelling study.</article-title><source><italic toggle="yes">Lancet</italic></source><volume>393</volume><fpage>2493</fpage>&#8211;<lpage>2502</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(18)32744-2</pub-id><pub-id pub-id-type="pmid">31076174</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marchitti</surname><given-names>S. A.</given-names></name><name name-style="western"><surname>Brocker</surname><given-names>C.</given-names></name><name name-style="western"><surname>Stagos</surname><given-names>D.</given-names></name><name name-style="western"><surname>Vasiliou</surname><given-names>V.</given-names></name></person-group> (<year>2008</year>). <article-title>Non-P450 aldehyde oxidizing enzymes: The aldehyde dehydrogenase superfamily.</article-title><source><italic toggle="yes">Expert Opin. Drug Metab. Toxicol</italic>.</source><volume>4</volume><fpage>697</fpage>&#8211;<lpage>720</lpage>. <pub-id pub-id-type="doi">10.1517/17425255.4.6.697</pub-id><pub-id pub-id-type="pmid">18611112</pub-id><pub-id pub-id-type="pmcid">PMC2658643</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mark</surname><given-names>R. J.</given-names></name><name name-style="western"><surname>Lovell</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Markesbery</surname><given-names>W. R.</given-names></name><name name-style="western"><surname>Uchida</surname><given-names>K.</given-names></name><name name-style="western"><surname>Mattson</surname><given-names>M. P.</given-names></name></person-group> (<year>1997</year>). <article-title>A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide.</article-title><source><italic toggle="yes">J. Neurochem</italic>.</source><volume>68</volume><fpage>255</fpage>&#8211;<lpage>264</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.1997.68010255.x</pub-id><pub-id pub-id-type="pmid">8978733</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Markesbery</surname><given-names>W. R.</given-names></name><name name-style="western"><surname>Lovell</surname><given-names>M. A.</given-names></name></person-group> (<year>1998</year>). <article-title>Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">Neurobiol. Aging</italic></source><volume>19</volume><fpage>33</fpage>&#8211;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/s0197-4580(98)00009-8</pub-id><pub-id pub-id-type="pmid">9562500</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Masters</surname><given-names>C. L.</given-names></name><name name-style="western"><surname>Bateman</surname><given-names>R.</given-names></name><name name-style="western"><surname>Blennow</surname><given-names>K.</given-names></name><name name-style="western"><surname>Rowe</surname><given-names>C. C.</given-names></name><name name-style="western"><surname>Sperling</surname><given-names>R. A.</given-names></name><name name-style="western"><surname>Cummings</surname><given-names>J. L.</given-names></name></person-group> (<year>2015</year>). <article-title>Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">Nat. Rev. Dis. Primers</italic></source><volume>1</volume>:<issue>15056</issue>. <pub-id pub-id-type="doi">10.1038/nrdp.2015.56</pub-id><pub-id pub-id-type="pmid">27188934</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mehder</surname><given-names>R. H.</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>B. M.</given-names></name><name name-style="western"><surname>Andrew</surname><given-names>R. D.</given-names></name></person-group> (<year>2020</year>). <article-title>Morphometric analysis of hippocampal and neocortical pyramidal neurons in a mouse model of late onset Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">J. Alzheimers Dis</italic>.</source><volume>74</volume><fpage>1069</fpage>&#8211;<lpage>1083</lpage>. <pub-id pub-id-type="doi">10.3233/jad-191067</pub-id><pub-id pub-id-type="pmid">32144984</pub-id><pub-id pub-id-type="pmcid">PMC7242838</pub-id></mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mehder</surname><given-names>R. H.</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>B. M.</given-names></name><name name-style="western"><surname>Andrew</surname><given-names>R. D.</given-names></name></person-group> (<year>2021</year>). <article-title>Age-related neuronal deterioration specifically within the dorsal CA1 region of the hippocampus in a mouse model of late onset Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">J. Alzheimers Dis</italic>.</source><volume>79</volume><fpage>1547</fpage>&#8211;<lpage>1561</lpage>. <pub-id pub-id-type="doi">10.3233/jad-201024</pub-id><pub-id pub-id-type="pmid">33459722</pub-id><pub-id pub-id-type="pmcid">PMC7990463</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mesches</surname><given-names>M. H.</given-names></name><name name-style="western"><surname>Gemma</surname><given-names>C.</given-names></name><name name-style="western"><surname>Veng</surname><given-names>L. M.</given-names></name><name name-style="western"><surname>Allgeier</surname><given-names>C.</given-names></name><name name-style="western"><surname>Young</surname><given-names>D. A.</given-names></name><name name-style="western"><surname>Browning</surname><given-names>M. D.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Sulindac improves memory and increases NMDA receptor subunits in aged Fischer 344 rats.</article-title><source><italic toggle="yes">Neurobiol. Aging</italic></source><volume>25</volume><fpage>315</fpage>&#8211;<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1016/s0197-4580(03)00116-7</pub-id><pub-id pub-id-type="pmid">15123337</pub-id></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meza</surname><given-names>V.</given-names></name><name name-style="western"><surname>Arnold</surname><given-names>J.</given-names></name><name name-style="western"><surname>D&#237;az</surname><given-names>L. A.</given-names></name><name name-style="western"><surname>Ayala Valverde</surname><given-names>M.</given-names></name><name name-style="western"><surname>Idalsoaga</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ayares</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Alcohol consumption: Medical implications, the liver and beyond.</article-title><source><italic toggle="yes">Alcohol Alcohol</italic>.</source><volume>57</volume><fpage>283</fpage>&#8211;<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1093/alcalc/agac013</pub-id><pub-id pub-id-type="pmid">35333295</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miller</surname><given-names>C. A.</given-names></name><name name-style="western"><surname>Gavin</surname><given-names>C. F.</given-names></name><name name-style="western"><surname>White</surname><given-names>J. A.</given-names></name><name name-style="western"><surname>Parrish</surname><given-names>R. R.</given-names></name><name name-style="western"><surname>Honasoge</surname><given-names>A.</given-names></name><name name-style="western"><surname>Yancey</surname><given-names>C. R.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Cortical DNA methylation maintains remote memory.</article-title><source><italic toggle="yes">Nat. Neurosci</italic>.</source><volume>13</volume><fpage>664</fpage>&#8211;<lpage>666</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2560</pub-id><pub-id pub-id-type="pmid">20495557</pub-id><pub-id pub-id-type="pmcid">PMC3043549</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morales</surname><given-names>R.</given-names></name><name name-style="western"><surname>Duran-Aniotz</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bravo-Alegria</surname><given-names>J.</given-names></name><name name-style="western"><surname>Estrada</surname><given-names>L. D.</given-names></name><name name-style="western"><surname>Shahnawaz</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>P. P.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Infusion of blood from mice displaying cerebral amyloidosis accelerates amyloid pathology in animal models of Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">Acta Neuropathol. Commun</italic>.</source><volume>8</volume>:<issue>213</issue>. <pub-id pub-id-type="doi">10.1186/s40478-020-01087-1</pub-id><pub-id pub-id-type="pmid">33287898</pub-id><pub-id pub-id-type="pmcid">PMC7720397</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hira</surname><given-names>A.</given-names></name><name name-style="western"><surname>Niwa</surname><given-names>A.</given-names></name><name name-style="western"><surname>Osawa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>K.</given-names></name><name name-style="western"><surname>Mori</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Analysis of disease model iPSCs derived from patients with a novel Fanconi anemia-like IBMFS ADH5/ALDH2 deficiency.</article-title><source><italic toggle="yes">Blood</italic></source><volume>137</volume><fpage>2021</fpage>&#8211;<lpage>2032</lpage>. <pub-id pub-id-type="doi">10.1182/blood.2020009111</pub-id><pub-id pub-id-type="pmid">33512438</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nannelli</surname><given-names>G.</given-names></name><name name-style="western"><surname>Terzuoli</surname><given-names>E.</given-names></name><name name-style="western"><surname>Giorgio</surname><given-names>V.</given-names></name><name name-style="western"><surname>Donnini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lupetti</surname><given-names>P.</given-names></name><name name-style="western"><surname>Giachetti</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>ALDH2 activity reduces mitochondrial oxygen reserve capacity in endothelial cells and induces senescence properties.</article-title><source><italic toggle="yes">Oxid. Med. Cell Longev</italic>.</source><volume>2018</volume>:<issue>9765027</issue>. <pub-id pub-id-type="doi">10.1155/2018/9765027</pub-id><pub-id pub-id-type="pmid">30538807</pub-id><pub-id pub-id-type="pmcid">PMC6261243</pub-id></mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nannelli</surname><given-names>G.</given-names></name><name name-style="western"><surname>Ziche</surname><given-names>M.</given-names></name><name name-style="western"><surname>Donnini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Morbidelli</surname><given-names>L.</given-names></name></person-group> (<year>2020</year>). <article-title>Endothelial aldehyde dehydrogenase 2 as a target to maintain vascular wellness and function in ageing.</article-title><source><italic toggle="yes">Biomedicines</italic></source><volume>8</volume>:<issue>4</issue>. <pub-id pub-id-type="doi">10.3390/biomedicines8010004</pub-id><pub-id pub-id-type="pmid">31947800</pub-id><pub-id pub-id-type="pmcid">PMC7168060</pub-id></mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nie</surname><given-names>C. L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X. S.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Perrett</surname><given-names>S.</given-names></name><name name-style="western"><surname>He</surname><given-names>R. Q.</given-names></name></person-group> (<year>2007a</year>). <article-title>Amyloid-like aggregates of neuronal tau induced by formaldehyde promote apoptosis of neuronal cells.</article-title><source><italic toggle="yes">BMC Neurosci</italic>.</source><volume>8</volume>:<issue>9</issue>. <pub-id pub-id-type="doi">10.1186/1471-2202-8-9</pub-id><pub-id pub-id-type="pmid">17241479</pub-id><pub-id pub-id-type="pmcid">PMC1790706</pub-id></mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nie</surname><given-names>C. L.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y. Y.</given-names></name><name name-style="western"><surname>Dui</surname><given-names>W.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2007b</year>). <article-title>Formaldehyde at low concentration induces protein tau into globular amyloid-like aggregates in vitro and in vivo.</article-title><source><italic toggle="yes">PLoS One</italic></source><volume>2</volume>:<issue>e629</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0000629</pub-id><pub-id pub-id-type="pmid">17637844</pub-id><pub-id pub-id-type="pmcid">PMC1913207</pub-id></mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nikhil</surname><given-names>K.</given-names></name><name name-style="western"><surname>Viccaro</surname><given-names>K.</given-names></name><name name-style="western"><surname>Shah</surname><given-names>K.</given-names></name></person-group> (<year>2019</year>). <article-title>Multifaceted regulation of ALDH1A1 by Cdk5 in Alzheimer&#8217;s disease pathogenesis.</article-title><source><italic toggle="yes">Mol. Neurobiol</italic>.</source><volume>56</volume><fpage>1366</fpage>&#8211;<lpage>1390</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-018-1114-9</pub-id><pub-id pub-id-type="pmid">29948941</pub-id><pub-id pub-id-type="pmcid">PMC6368892</pub-id></mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Obermeier</surname><given-names>B.</given-names></name><name name-style="western"><surname>Daneman</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ransohoff</surname><given-names>R. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Development, maintenance and disruption of the blood-brain barrier.</article-title><source><italic toggle="yes">Nat. Med</italic>.</source><volume>19</volume><fpage>1584</fpage>&#8211;<lpage>1596</lpage>. <pub-id pub-id-type="doi">10.1038/nm.3407</pub-id><pub-id pub-id-type="pmid">24309662</pub-id><pub-id pub-id-type="pmcid">PMC4080800</pub-id></mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ohsawa</surname><given-names>I.</given-names></name><name name-style="western"><surname>Nishimaki</surname><given-names>K.</given-names></name><name name-style="western"><surname>Murakami</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ishikawa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ohta</surname><given-names>S.</given-names></name></person-group> (<year>2008</year>). <article-title>Age-dependent neurodegeneration accompanying memory loss in transgenic mice defective in mitochondrial aldehyde dehydrogenase 2 activity.</article-title><source><italic toggle="yes">J. Neurosci</italic>.</source><volume>28</volume><fpage>6239</fpage>&#8211;<lpage>6249</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.4956-07.2008</pub-id><pub-id pub-id-type="pmid">18550766</pub-id><pub-id pub-id-type="pmcid">PMC6670537</pub-id></mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ohsawa</surname><given-names>I.</given-names></name><name name-style="western"><surname>Nishimaki</surname><given-names>K.</given-names></name><name name-style="western"><surname>Yasuda</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kamino</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ohta</surname><given-names>S.</given-names></name></person-group> (<year>2003</year>). <article-title>Deficiency in a mitochondrial aldehyde dehydrogenase increases vulnerability to oxidative stress in PC12 cells.</article-title><source><italic toggle="yes">J. Neurochem</italic>.</source><volume>84</volume><fpage>1110</fpage>&#8211;<lpage>1117</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.2003.01619.x</pub-id><pub-id pub-id-type="pmid">12603834</pub-id></mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ohta</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ohsawa</surname><given-names>I.</given-names></name><name name-style="western"><surname>Kamino</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ando</surname><given-names>F.</given-names></name><name name-style="western"><surname>Shimokata</surname><given-names>H.</given-names></name></person-group> (<year>2004</year>). <article-title>Mitochondrial ALDH2 deficiency as an oxidative stress.</article-title><source><italic toggle="yes">Ann. N. Y. Acad. Sci</italic>.</source><volume>1011</volume><fpage>36</fpage>&#8211;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-662-41088-2_4</pub-id><pub-id pub-id-type="pmid">15126281</pub-id></mixed-citation></ref><ref id="B108"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Orme&#241;o</surname><given-names>D.</given-names></name><name name-style="western"><surname>Romero</surname><given-names>F.</given-names></name><name name-style="western"><surname>L&#243;pez-Fenner</surname><given-names>J.</given-names></name><name name-style="western"><surname>Avila</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mart&#237;nez-Torres</surname><given-names>A.</given-names></name><name name-style="western"><surname>Parodi</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>Ethanol reduces amyloid aggregation in vitro and prevents toxicity in cell lines.</article-title><source><italic toggle="yes">Arch. Med. Res</italic>.</source><volume>44</volume><fpage>1</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.arcmed.2012.12.004</pub-id><pub-id pub-id-type="pmid">23291379</pub-id></mixed-citation></ref><ref id="B109"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Owen</surname><given-names>J. B.</given-names></name><name name-style="western"><surname>Sultana</surname><given-names>R.</given-names></name><name name-style="western"><surname>Aluise</surname><given-names>C. D.</given-names></name><name name-style="western"><surname>Erickson</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Price</surname><given-names>T. O.</given-names></name><name name-style="western"><surname>Bu</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: Implications for A&#946; accumulation in AD brain.</article-title><source><italic toggle="yes">Free Radic. Biol. Med</italic>.</source><volume>49</volume><fpage>1798</fpage>&#8211;<lpage>1803</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2010.09.013</pub-id><pub-id pub-id-type="pmid">20869432</pub-id><pub-id pub-id-type="pmcid">PMC2970765</pub-id></mixed-citation></ref><ref id="B110"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Padurariu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ciobica</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lefter</surname><given-names>R.</given-names></name><name name-style="western"><surname>Serban</surname><given-names>I. L.</given-names></name><name name-style="western"><surname>Stefanescu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Chirita</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>The oxidative stress hypothesis in Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">Psychiatr. Danub</italic>.</source><volume>25</volume><fpage>401</fpage>&#8211;<lpage>409</lpage>.<pub-id pub-id-type="pmid">24247053</pub-id></mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parodi</surname><given-names>J.</given-names></name><name name-style="western"><surname>Orme&#241;o</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ochoa-de la Paz</surname><given-names>L. D.</given-names></name></person-group> (<year>2015</year>). <article-title>Amyloid pore-channel hypothesis: Effect of ethanol on aggregation state using frog oocytes for an Alzheimer&#8217;s disease study.</article-title><source><italic toggle="yes">BMB Rep</italic>.</source><volume>48</volume><fpage>13</fpage>&#8211;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.5483/bmbrep.2015.48.1.125</pub-id><pub-id pub-id-type="pmid">25047445</pub-id><pub-id pub-id-type="pmcid">PMC4345636</pub-id></mixed-citation></ref><ref id="B112"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peng</surname><given-names>B.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>B Joshi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Akbar</surname><given-names>M.</given-names></name><name name-style="western"><surname>Song</surname><given-names>B. J.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Role of alcohol drinking in Alzheimer&#8217;s disease, Parkinson&#8217;s disease, and amyotrophic lateral sclerosis.</article-title><source><italic toggle="yes">Int. J. Mol. Sci</italic>.</source><volume>21</volume>:<issue>2316</issue>. <pub-id pub-id-type="doi">10.3390/ijms21072316</pub-id><pub-id pub-id-type="pmid">32230811</pub-id><pub-id pub-id-type="pmcid">PMC7177420</pub-id></mixed-citation></ref><ref id="B113"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perluigi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Coccia</surname><given-names>R.</given-names></name><name name-style="western"><surname>Butterfield</surname><given-names>D. A.</given-names></name></person-group> (<year>2012</year>). <article-title>4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: A toxic combination illuminated by redox proteomics studies.</article-title><source><italic toggle="yes">Antioxid. Redox Signal</italic>.</source><volume>17</volume><fpage>1590</fpage>&#8211;<lpage>1609</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2011.4406</pub-id><pub-id pub-id-type="pmid">22114878</pub-id><pub-id pub-id-type="pmcid">PMC3449441</pub-id></mixed-citation></ref><ref id="B114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perluigi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sultana</surname><given-names>R.</given-names></name><name name-style="western"><surname>Cenini</surname><given-names>G.</given-names></name><name name-style="western"><surname>Di Domenico</surname><given-names>F.</given-names></name><name name-style="western"><surname>Memo</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pierce</surname><given-names>W. M.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Redox proteomics identification of 4-hydroxynonenal-modified brain proteins in Alzheimer&#8217;s disease: Role of lipid peroxidation in Alzheimer&#8217;s disease pathogenesis.</article-title><source><italic toggle="yes">Proteom. Clin. Appl</italic>.</source><volume>3</volume><fpage>682</fpage>&#8211;<lpage>693</lpage>. <pub-id pub-id-type="doi">10.1002/prca.200800161</pub-id><pub-id pub-id-type="pmid">20333275</pub-id><pub-id pub-id-type="pmcid">PMC2843938</pub-id></mixed-citation></ref><ref id="B115"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pimentel</surname><given-names>E.</given-names></name><name name-style="western"><surname>Sivalingam</surname><given-names>K.</given-names></name><name name-style="western"><surname>Doke</surname><given-names>M.</given-names></name><name name-style="western"><surname>Samikkannu</surname><given-names>T.</given-names></name></person-group> (<year>2020</year>). <article-title>Effects of drugs of abuse on the blood-brain barrier: A brief overview.</article-title><source><italic toggle="yes">Front. Neurosci</italic>.</source><volume>14</volume>:<issue>513</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2020.00513</pub-id><pub-id pub-id-type="pmid">32670001</pub-id><pub-id pub-id-type="pmcid">PMC7326150</pub-id></mixed-citation></ref><ref id="B116"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Piumatti</surname><given-names>G.</given-names></name><name name-style="western"><surname>Moore</surname><given-names>S. C.</given-names></name><name name-style="western"><surname>Berridge</surname><given-names>D. M.</given-names></name><name name-style="western"><surname>Sarkar</surname><given-names>C.</given-names></name><name name-style="western"><surname>Gallacher</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>The relationship between alcohol use and long-term cognitive decline in middle and late life: A longitudinal analysis using UK Biobank.</article-title><source><italic toggle="yes">J. Public Health</italic></source><volume>40</volume><fpage>304</fpage>&#8211;<lpage>311</lpage>. <pub-id pub-id-type="doi">10.1093/pubmed/fdx186</pub-id><pub-id pub-id-type="pmid">29325150</pub-id><pub-id pub-id-type="pmcid">PMC6051452</pub-id></mixed-citation></ref><ref id="B117"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pratic&#242;</surname><given-names>D.</given-names></name></person-group> (<year>2008</year>). <article-title>Oxidative stress hypothesis in Alzheimer&#8217;s disease: A reappraisal.</article-title><source><italic toggle="yes">Trends Pharmacol. Sci</italic>.</source><volume>29</volume><fpage>609</fpage>&#8211;<lpage>615</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2008.09.001</pub-id><pub-id pub-id-type="pmid">18838179</pub-id></mixed-citation></ref><ref id="B118"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pratic&#242;</surname><given-names>D.</given-names></name><name name-style="western"><surname>Uryu</surname><given-names>K.</given-names></name><name name-style="western"><surname>Leight</surname><given-names>S.</given-names></name><name name-style="western"><surname>Trojanoswki</surname><given-names>J. Q.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>V. M.</given-names></name></person-group> (<year>2001</year>). <article-title>Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis.</article-title><source><italic toggle="yes">J. Neurosci</italic>.</source><volume>21</volume><fpage>4183</fpage>&#8211;<lpage>4187</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.21-12-04183.2001</pub-id><pub-id pub-id-type="pmid">11404403</pub-id><pub-id pub-id-type="pmcid">PMC6762743</pub-id></mixed-citation></ref><ref id="B119"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rajgopal</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Vemuri</surname><given-names>M. C.</given-names></name></person-group> (<year>2001</year>). <article-title>Ethanol induced changes in cyclin-dependent kinase-5 activity and its activators, P35, P67 (Munc-18) in rat brain.</article-title><source><italic toggle="yes">Neurosci. Lett</italic>.</source><volume>308</volume><fpage>173</fpage>&#8211;<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1016/s0304-3940(01)02011-0</pub-id><pub-id pub-id-type="pmid">11479016</pub-id></mixed-citation></ref><ref id="B120"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramos</surname><given-names>A.</given-names></name><name name-style="western"><surname>Joshi</surname><given-names>R. S.</given-names></name><name name-style="western"><surname>Szabo</surname><given-names>G.</given-names></name></person-group> (<year>2022</year>). <article-title>Innate immune activation: Parallels in alcohol use disorder and Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">Front. Mol. Neurosci</italic>.</source><volume>15</volume>:<issue>910298</issue>. <pub-id pub-id-type="doi">10.3389/fnmol.2022.910298</pub-id><pub-id pub-id-type="pmid">36157070</pub-id><pub-id pub-id-type="pmcid">PMC9505690</pub-id></mixed-citation></ref><ref id="B121"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ran</surname><given-names>L. S.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W. H.</given-names></name><name name-style="western"><surname>Fang</surname><given-names>Y. Y.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>S. B.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Alcohol, coffee and tea intake and the risk of cognitive deficits: A dose-response meta-analysis.</article-title><source><italic toggle="yes">Epidemiol. Psychiatr. Sci</italic>.</source><volume>30</volume>:<issue>e13</issue>. <pub-id pub-id-type="doi">10.1017/s2045796020001183</pub-id><pub-id pub-id-type="pmid">33568254</pub-id><pub-id pub-id-type="pmcid">PMC8061189</pub-id></mixed-citation></ref><ref id="B122"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reale</surname><given-names>M.</given-names></name><name name-style="western"><surname>Costantini</surname><given-names>E.</given-names></name><name name-style="western"><surname>Jagarlapoodi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>H.</given-names></name><name name-style="western"><surname>Belwal</surname><given-names>T.</given-names></name><name name-style="western"><surname>Cichelli</surname><given-names>A.</given-names></name></person-group> (<year>2020</year>). <article-title>Relationship of wine consumption with Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">Nutrients</italic></source><volume>12</volume>:<issue>206</issue>. <pub-id pub-id-type="doi">10.3390/nu12010206</pub-id><pub-id pub-id-type="pmid">31941117</pub-id><pub-id pub-id-type="pmcid">PMC7019227</pub-id></mixed-citation></ref><ref id="B123"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reed</surname><given-names>T. T.</given-names></name><name name-style="western"><surname>Pierce</surname><given-names>W. M.</given-names></name><name name-style="western"><surname>Markesbery</surname><given-names>W. R.</given-names></name><name name-style="western"><surname>Butterfield</surname><given-names>D. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD.</article-title><source><italic toggle="yes">Brain Res</italic>.</source><volume>1274</volume><fpage>66</fpage>&#8211;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2009.04.009</pub-id><pub-id pub-id-type="pmid">19374891</pub-id></mixed-citation></ref><ref id="B124"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Resende</surname><given-names>R.</given-names></name><name name-style="western"><surname>Moreira</surname><given-names>P. I.</given-names></name><name name-style="western"><surname>Proen&#231;a</surname><given-names>T.</given-names></name><name name-style="western"><surname>Deshpande</surname><given-names>A.</given-names></name><name name-style="western"><surname>Busciglio</surname><given-names>J.</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease.</article-title><source><italic toggle="yes">Free Radic. Biol. Med</italic>.</source><volume>44</volume><fpage>2051</fpage>&#8211;<lpage>2057</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2008.03.012</pub-id><pub-id pub-id-type="pmid">18423383</pub-id></mixed-citation></ref><ref id="B125"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodr&#237;guez-Zavala</surname><given-names>J. S.</given-names></name><name name-style="western"><surname>Calleja</surname><given-names>L. F.</given-names></name><name name-style="western"><surname>Moreno-S&#225;nchez</surname><given-names>R.</given-names></name><name name-style="western"><surname>Yoval-S&#225;nchez</surname><given-names>B.</given-names></name></person-group> (<year>2019</year>). <article-title>Role of aldehyde dehydrogenases in physiopathological processes.</article-title><source><italic toggle="yes">Chem. Res. Toxicol</italic>.</source><volume>32</volume><fpage>405</fpage>&#8211;<lpage>420</lpage>. <pub-id pub-id-type="doi">10.1021/acs.chemrestox.8b00256</pub-id><pub-id pub-id-type="pmid">30628442</pub-id></mixed-citation></ref><ref id="B126"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roy</surname><given-names>B.</given-names></name><name name-style="western"><surname>Palaniyandi</surname><given-names>S. S.</given-names></name></person-group> (<year>2020</year>). <article-title>Aldehyde dehydrogenase 2 inhibition potentiates 4-hydroxy-2-nonenal induced decrease in angiogenesis of coronary endothelial cells.</article-title><source><italic toggle="yes">Cell Biochem. Funct</italic>.</source><volume>38</volume><fpage>290</fpage>&#8211;<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1002/cbf.3468</pub-id><pub-id pub-id-type="pmid">31943249</pub-id></mixed-citation></ref><ref id="B127"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roy</surname><given-names>B.</given-names></name><name name-style="western"><surname>Sundar</surname><given-names>K.</given-names></name><name name-style="western"><surname>Palaniyandi</surname><given-names>S. S.</given-names></name></person-group> (<year>2020</year>). <article-title>4-hydroxy-2-nonenal decreases coronary endothelial cell migration: Potentiation by aldehyde dehydrogenase 2 inhibition.</article-title><source><italic toggle="yes">Vascul. Pharmacol</italic>.</source><volume>131</volume>:<issue>106762</issue>. <pub-id pub-id-type="doi">10.1016/j.vph.2020.106762</pub-id><pub-id pub-id-type="pmid">32585188</pub-id></mixed-citation></ref><ref id="B128"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rubio-Araiz</surname><given-names>A.</given-names></name><name name-style="western"><surname>Porcu</surname><given-names>F.</given-names></name><name name-style="western"><surname>P&#233;rez-Hern&#225;ndez</surname><given-names>M.</given-names></name><name name-style="western"><surname>Garc&#237;a-Guti&#233;rrez</surname><given-names>M. S.</given-names></name><name name-style="western"><surname>Aracil-Fern&#225;ndez</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Gutierrez-L&#243;pez</surname><given-names>M. D.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Disruption of blood-brain barrier integrity in postmortem alcoholic brain: Preclinical evidence of TLR4 involvement from a binge-like drinking model.</article-title><source><italic toggle="yes">Addict. Biol</italic>.</source><volume>22</volume><fpage>1103</fpage>&#8211;<lpage>1116</lpage>. <pub-id pub-id-type="doi">10.1111/adb.12376</pub-id><pub-id pub-id-type="pmid">26949123</pub-id></mixed-citation></ref><ref id="B129"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rumgay</surname><given-names>H.</given-names></name><name name-style="western"><surname>Shield</surname><given-names>K.</given-names></name><name name-style="western"><surname>Charvat</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ferrari</surname><given-names>P.</given-names></name><name name-style="western"><surname>Sornpaisarn</surname><given-names>B.</given-names></name><name name-style="western"><surname>Obot</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Global burden of cancer in 2020 attributable to alcohol consumption: A population-based study.</article-title><source><italic toggle="yes">Lancet Oncol</italic>.</source><volume>22</volume><fpage>1071</fpage>&#8211;<lpage>1080</lpage>. <pub-id pub-id-type="doi">10.1016/s1470-2045(21)00279-5</pub-id><pub-id pub-id-type="pmid">34270924</pub-id><pub-id pub-id-type="pmcid">PMC8324483</pub-id></mixed-citation></ref><ref id="B130"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sabia</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fayosse</surname><given-names>A.</given-names></name><name name-style="western"><surname>Dumurgier</surname><given-names>J.</given-names></name><name name-style="western"><surname>Dugravot</surname><given-names>A.</given-names></name><name name-style="western"><surname>Akbaraly</surname><given-names>T.</given-names></name><name name-style="western"><surname>Britton</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Alcohol consumption and risk of dementia: 23 year follow-up of Whitehall II cohort study.</article-title><source><italic toggle="yes">BMJ</italic></source><volume>362</volume>:<issue>k2927</issue>. <pub-id pub-id-type="doi">10.1136/bmj.k2927</pub-id><pub-id pub-id-type="pmid">30068508</pub-id><pub-id pub-id-type="pmcid">PMC6066998</pub-id></mixed-citation></ref><ref id="B131"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sayre</surname><given-names>L. M.</given-names></name><name name-style="western"><surname>Zelasko</surname><given-names>D. A.</given-names></name><name name-style="western"><surname>Harris</surname><given-names>P. L.</given-names></name><name name-style="western"><surname>Perry</surname><given-names>G.</given-names></name><name name-style="western"><surname>Salomon</surname><given-names>R. G.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>M. A.</given-names></name></person-group> (<year>1997</year>). <article-title>4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">J. Neurochem</italic>.</source><volume>68</volume><fpage>2092</fpage>&#8211;<lpage>2097</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.1997.68052092.x</pub-id><pub-id pub-id-type="pmid">9109537</pub-id></mixed-citation></ref><ref id="B132"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scheltens</surname><given-names>P.</given-names></name><name name-style="western"><surname>De Strooper</surname><given-names>B.</given-names></name><name name-style="western"><surname>Kivipelto</surname><given-names>M.</given-names></name><name name-style="western"><surname>Holstege</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ch&#233;telat</surname><given-names>G.</given-names></name><name name-style="western"><surname>Teunissen</surname><given-names>C. E.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">Lancet</italic></source><volume>397</volume><fpage>1577</fpage>&#8211;<lpage>1590</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(20)32205-4</pub-id><pub-id pub-id-type="pmid">33667416</pub-id><pub-id pub-id-type="pmcid">PMC8354300</pub-id></mixed-citation></ref><ref id="B133"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schneider</surname><given-names>J. A.</given-names></name><name name-style="western"><surname>Arvanitakis</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Bang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>D. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Mixed brain pathologies account for most dementia cases in community-dwelling older persons.</article-title><source><italic toggle="yes">Neurology</italic></source><volume>69</volume><fpage>2197</fpage>&#8211;<lpage>2204</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000271090.28148.24</pub-id><pub-id pub-id-type="pmid">17568013</pub-id></mixed-citation></ref><ref id="B134"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schwarzinger</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pollock</surname><given-names>B. G.</given-names></name><name name-style="western"><surname>Hasan</surname><given-names>O. S. M.</given-names></name><name name-style="western"><surname>Dufouil</surname><given-names>C.</given-names></name><name name-style="western"><surname>Rehm</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>Contribution of alcohol use disorders to the burden of dementia in France 2008-13: A nationwide retrospective cohort study.</article-title><source><italic toggle="yes">Lancet Public Health</italic></source><volume>3</volume><fpage>e124</fpage>&#8211;<lpage>e132</lpage>. <pub-id pub-id-type="doi">10.1016/s2468-2667(18)30022-7</pub-id><pub-id pub-id-type="pmid">29475810</pub-id></mixed-citation></ref><ref id="B135"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seike</surname><given-names>T.</given-names></name><name name-style="western"><surname>Boontem</surname><given-names>P.</given-names></name><name name-style="western"><surname>Yanagi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kido</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yamamiya</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Hydroxynonenal causes hepatocyte death by disrupting lysosomal integrity in nonalcoholic steatohepatitis.</article-title><source><italic toggle="yes">Cell Mol. Gastroenterol. Hepatol</italic>.</source><volume>14</volume><fpage>925</fpage>&#8211;<lpage>944</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcmgh.2022.06.008</pub-id><pub-id pub-id-type="pmid">35787976</pub-id><pub-id pub-id-type="pmcid">PMC9500440</pub-id></mixed-citation></ref><ref id="B136"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seike</surname><given-names>T.</given-names></name><name name-style="western"><surname>Mizukoshi</surname><given-names>E.</given-names></name><name name-style="western"><surname>Kaneko</surname><given-names>S.</given-names></name></person-group> (<year>2021</year>). <article-title>Role of CD4+ T-cells in the pathology of non-alcoholic fatty liver disease and related diseases.</article-title><source><italic toggle="yes">Hepatoma Res</italic>.</source><volume>7</volume>:<issue>46</issue>. <pub-id pub-id-type="doi">10.20517/2394-5079.2021.46</pub-id></mixed-citation></ref><ref id="B137"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seike</surname><given-names>T.</given-names></name><name name-style="western"><surname>Mizukoshi</surname><given-names>E.</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>K.</given-names></name><name name-style="western"><surname>Okada</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kitahara</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yamashita</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Fatty acid-driven modifications in T-cell profiles in non-alcoholic fatty liver disease patients.</article-title><source><italic toggle="yes">J. Gastroenterol</italic>.</source><volume>55</volume><fpage>701</fpage>&#8211;<lpage>711</lpage>. <pub-id pub-id-type="doi">10.1007/s00535-020-01679-7</pub-id><pub-id pub-id-type="pmid">32124081</pub-id></mixed-citation></ref><ref id="B138"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seshadri</surname><given-names>S.</given-names></name><name name-style="western"><surname>Beiser</surname><given-names>A.</given-names></name><name name-style="western"><surname>Selhub</surname><given-names>J.</given-names></name><name name-style="western"><surname>Jacques</surname><given-names>P. F.</given-names></name><name name-style="western"><surname>Rosenberg</surname><given-names>I. H.</given-names></name><name name-style="western"><surname>D&#8217;Agostino</surname><given-names>R. B.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Plasma homocysteine as a risk factor for dementia and Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">N. Engl. J. Med</italic>.</source><volume>346</volume><fpage>476</fpage>&#8211;<lpage>483</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa011613</pub-id><pub-id pub-id-type="pmid">11844848</pub-id></mixed-citation></ref><ref id="B139"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shimizu</surname><given-names>E.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y. P.</given-names></name><name name-style="western"><surname>Rampon</surname><given-names>C.</given-names></name><name name-style="western"><surname>Tsien</surname><given-names>J. Z.</given-names></name></person-group> (<year>2000</year>). <article-title>NMDA receptor-dependent synaptic reinforcement as a crucial process for memory consolidation.</article-title><source><italic toggle="yes">Science</italic></source><volume>290</volume><fpage>1170</fpage>&#8211;<lpage>1174</lpage>. <pub-id pub-id-type="doi">10.1126/science.290.5494.1170</pub-id><pub-id pub-id-type="pmid">11073458</pub-id></mixed-citation></ref><ref id="B140"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shin</surname><given-names>I. S.</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J. M.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S. W.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>Shin</surname><given-names>H. Y.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Mitochondrial aldehyde dehydrogenase polymorphism is not associated with incidence of Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">Int. J. Geriatr. Psychiatry</italic></source><volume>20</volume><fpage>1075</fpage>&#8211;<lpage>1080</lpage>. <pub-id pub-id-type="doi">10.1002/gps.1401</pub-id><pub-id pub-id-type="pmid">16250071</pub-id></mixed-citation></ref><ref id="B141"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shin</surname><given-names>S. W.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>D. H.</given-names></name><name name-style="western"><surname>Jeon</surname><given-names>W. K.</given-names></name><name name-style="western"><surname>Han</surname><given-names>J. S.</given-names></name></person-group> (<year>2020</year>). <article-title>4-hydroxynonenal immunoreactivity is increased in the frontal cortex of 5XFAD transgenic mice.</article-title><source><italic toggle="yes">Biomedicines</italic></source><volume>8</volume>:<issue>326</issue>. <pub-id pub-id-type="doi">10.3390/biomedicines8090326</pub-id><pub-id pub-id-type="pmid">32899155</pub-id><pub-id pub-id-type="pmcid">PMC7554765</pub-id></mixed-citation></ref><ref id="B142"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shringarpure</surname><given-names>R.</given-names></name><name name-style="western"><surname>Grune</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sitte</surname><given-names>N.</given-names></name><name name-style="western"><surname>Davies</surname><given-names>K. J.</given-names></name></person-group> (<year>2000</year>). <article-title>4-Hydroxynonenal-modified amyloid-beta peptide inhibits the proteasome: Possible importance in Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">Cell Mol. Life Sci</italic>.</source><volume>57</volume><fpage>1802</fpage>&#8211;<lpage>1809</lpage>. <pub-id pub-id-type="doi">10.1007/pl00000660</pub-id><pub-id pub-id-type="pmid">11130184</pub-id><pub-id pub-id-type="pmcid">PMC11149552</pub-id></mixed-citation></ref><ref id="B143"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siegel</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>Bieschke</surname><given-names>J.</given-names></name><name name-style="western"><surname>Powers</surname><given-names>E. T.</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>J. W.</given-names></name></person-group> (<year>2007</year>). <article-title>The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofibril formation.</article-title><source><italic toggle="yes">Biochemistry</italic></source><volume>46</volume><fpage>1503</fpage>&#8211;<lpage>1510</lpage>. <pub-id pub-id-type="doi">10.1021/bi061853s</pub-id><pub-id pub-id-type="pmid">17279615</pub-id><pub-id pub-id-type="pmcid">PMC2530822</pub-id></mixed-citation></ref><ref id="B144"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>A. K.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>S.</given-names></name><name name-style="western"><surname>Benlhabib</surname><given-names>E.</given-names></name></person-group> (<year>2007</year>). <article-title>Effects of chronic ethanol drinking on the blood brain barrier and ensuing neuronal toxicity in alcohol-preferring rats subjected to intraperitoneal LPS injection.</article-title><source><italic toggle="yes">Alcohol Alcohol</italic>.</source><volume>42</volume><fpage>385</fpage>&#8211;<lpage>399</lpage>. <pub-id pub-id-type="doi">10.1093/alcalc/agl120</pub-id><pub-id pub-id-type="pmid">17341516</pub-id></mixed-citation></ref><ref id="B145"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spence</surname><given-names>J. P.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>T.</given-names></name><name name-style="western"><surname>Eriksson</surname><given-names>C. J.</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>R. E.</given-names></name><name name-style="western"><surname>Wall</surname><given-names>T. L.</given-names></name><name name-style="western"><surname>Ehlers</surname><given-names>C. L.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Evaluation of aldehyde dehydrogenase 1 promoter polymorphisms identified in human populations.</article-title><source><italic toggle="yes">Alcohol Clin. Exp. Res</italic>.</source><volume>27</volume><fpage>1389</fpage>&#8211;<lpage>1394</lpage>. <pub-id pub-id-type="doi">10.1097/01.Alc.0000087086.50089.59</pub-id><pub-id pub-id-type="pmid">14506398</pub-id><pub-id pub-id-type="pmcid">PMC4560114</pub-id></mixed-citation></ref><ref id="B146"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sultana</surname><given-names>R.</given-names></name><name name-style="western"><surname>Perluigi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Butterfield</surname><given-names>D. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Lipid peroxidation triggers neurodegeneration: A redox proteomics view into the Alzheimer disease brain.</article-title><source><italic toggle="yes">Free Radic. Biol. Med</italic>.</source><volume>62</volume><fpage>157</fpage>&#8211;<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2012.09.027</pub-id><pub-id pub-id-type="pmid">23044265</pub-id><pub-id pub-id-type="pmcid">PMC3573239</pub-id></mixed-citation></ref><ref id="B147"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sweeney</surname><given-names>M. D.</given-names></name><name name-style="western"><surname>Sagare</surname><given-names>A. P.</given-names></name><name name-style="western"><surname>Zlokovic</surname><given-names>B. V.</given-names></name></person-group> (<year>2018</year>). <article-title>Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.</article-title><source><italic toggle="yes">Nat. Rev. Neurol</italic>.</source><volume>14</volume><fpage>133</fpage>&#8211;<lpage>150</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2017.188</pub-id><pub-id pub-id-type="pmid">29377008</pub-id><pub-id pub-id-type="pmcid">PMC5829048</pub-id></mixed-citation></ref><ref id="B148"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tamagno</surname><given-names>E.</given-names></name><name name-style="western"><surname>Bardini</surname><given-names>P.</given-names></name><name name-style="western"><surname>Obbili</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vitali</surname><given-names>A.</given-names></name><name name-style="western"><surname>Borghi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Zaccheo</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Oxidative stress increases expression and activity of BACE in NT2 neurons.</article-title><source><italic toggle="yes">Neurobiol. Dis</italic>.</source><volume>10</volume><fpage>279</fpage>&#8211;<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1006/nbdi.2002.0515</pub-id><pub-id pub-id-type="pmid">12270690</pub-id></mixed-citation></ref><ref id="B149"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tamagno</surname><given-names>E.</given-names></name><name name-style="western"><surname>Parola</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bardini</surname><given-names>P.</given-names></name><name name-style="western"><surname>Piccini</surname><given-names>A.</given-names></name><name name-style="western"><surname>Borghi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Guglielmotto</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways.</article-title><source><italic toggle="yes">J. Neurochem</italic>.</source><volume>92</volume><fpage>628</fpage>&#8211;<lpage>636</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2004.02895.x</pub-id><pub-id pub-id-type="pmid">15659232</pub-id></mixed-citation></ref><ref id="B150"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tan</surname><given-names>T.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>W.</given-names></name><name name-style="western"><surname>Lv</surname><given-names>J.</given-names></name><name name-style="western"><surname>Han</surname><given-names>C.</given-names></name><name name-style="western"><surname>Hamlin</surname><given-names>J. N. R.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Formaldehyde induces diabetes-associated cognitive impairments.</article-title><source><italic toggle="yes">FASEB J</italic>.</source><volume>32</volume><fpage>3669</fpage>&#8211;<lpage>3679</lpage>. <pub-id pub-id-type="doi">10.1096/fj.201701239R</pub-id><pub-id pub-id-type="pmid">29401634</pub-id></mixed-citation></ref><ref id="B151"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tandon</surname><given-names>R.</given-names></name><name name-style="western"><surname>Levey</surname><given-names>A. I.</given-names></name><name name-style="western"><surname>Lah</surname><given-names>J. J.</given-names></name><name name-style="western"><surname>Seyfried</surname><given-names>N. T.</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>C. S.</given-names></name></person-group> (<year>2023</year>). <article-title>Machine learning selection of most predictive brain proteins suggests role of sugar metabolism in Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">J. Alzheimers Dis</italic>.</source><volume>92</volume><fpage>411</fpage>&#8211;<lpage>424</lpage>. <pub-id pub-id-type="doi">10.3233/jad-220683</pub-id><pub-id pub-id-type="pmid">36776048</pub-id><pub-id pub-id-type="pmcid">PMC10041447</pub-id></mixed-citation></ref><ref id="B152"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tao</surname><given-names>R.</given-names></name><name name-style="western"><surname>Liao</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Qin</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>In situ imaging of formaldehyde in live mice with high spatiotemporal resolution reveals aldehyde dehydrogenase-2 as a potential target for Alzheimer&#8217;s disease treatment.</article-title><source><italic toggle="yes">Anal. Chem</italic>.</source><volume>94</volume><fpage>1308</fpage>&#8211;<lpage>1317</lpage>. <pub-id pub-id-type="doi">10.1021/acs.analchem.1c04520</pub-id><pub-id pub-id-type="pmid">34962779</pub-id></mixed-citation></ref><ref id="B153"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Teng</surname><given-names>S.</given-names></name><name name-style="western"><surname>Beard</surname><given-names>K.</given-names></name><name name-style="western"><surname>Pourahmad</surname><given-names>J.</given-names></name><name name-style="western"><surname>Moridani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Easson</surname><given-names>E.</given-names></name><name name-style="western"><surname>Poon</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>The formaldehyde metabolic detoxification enzyme systems and molecular cytotoxic mechanism in isolated rat hepatocytes.</article-title><source><italic toggle="yes">Chem. Biol. Interact</italic>.</source><volume>130-132</volume><fpage>285</fpage>&#8211;<lpage>296</lpage>. <pub-id pub-id-type="doi">10.1016/s0009-2797(00)00272-6</pub-id><pub-id pub-id-type="pmid">11306052</pub-id></mixed-citation></ref><ref id="B154"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tong</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Han</surname><given-names>C.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>W.</given-names></name><name name-style="western"><surname>Li</surname><given-names>H.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>H.</given-names></name><name name-style="western"><surname>Qiang</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2013a</year>). <article-title>Aging-associated excess formaldehyde leads to spatial memory deficits.</article-title><source><italic toggle="yes">Sci. Rep</italic>.</source><volume>3</volume>:<issue>1807</issue>. <pub-id pub-id-type="doi">10.1038/srep01807</pub-id><pub-id pub-id-type="pmid">23657727</pub-id><pub-id pub-id-type="pmcid">PMC3648839</pub-id></mixed-citation></ref><ref id="B155"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tong</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Han</surname><given-names>C.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>W.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Li</surname><given-names>H.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2013b</year>). <article-title>Accumulated hippocampal formaldehyde induces age-dependent memory decline.</article-title><source><italic toggle="yes">Age</italic></source><volume>35</volume><fpage>583</fpage>&#8211;<lpage>596</lpage>. <pub-id pub-id-type="doi">10.1007/s11357-012-9388-8</pub-id><pub-id pub-id-type="pmid">22382760</pub-id><pub-id pub-id-type="pmcid">PMC3636394</pub-id></mixed-citation></ref><ref id="B156"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tong</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Han</surname><given-names>C.</given-names></name><name name-style="western"><surname>Qiang</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Lv</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Age-related formaldehyde interferes with DNA methyltransferase function, causing memory loss in Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">Neurobiol. Aging</italic></source><volume>36</volume><fpage>100</fpage>&#8211;<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2014.07.018</pub-id><pub-id pub-id-type="pmid">25282336</pub-id></mixed-citation></ref><ref id="B157"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tong</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>W.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Li</surname><given-names>F.</given-names></name><name name-style="western"><surname>Li</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia.</article-title><source><italic toggle="yes">Neurobiol. Aging</italic></source><volume>32</volume><fpage>31</fpage>&#8211;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2009.07.013</pub-id><pub-id pub-id-type="pmid">19879019</pub-id></mixed-citation></ref><ref id="B158"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Topiwala</surname><given-names>A.</given-names></name><name name-style="western"><surname>Allan</surname><given-names>C. L.</given-names></name><name name-style="western"><surname>Valkanova</surname><given-names>V.</given-names></name><name name-style="western"><surname>Zsoldos</surname><given-names>E.</given-names></name><name name-style="western"><surname>Filippini</surname><given-names>N.</given-names></name><name name-style="western"><surname>Sexton</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Moderate alcohol consumption as risk factor for adverse brain outcomes and cognitive decline: Longitudinal cohort study.</article-title><source><italic toggle="yes">BMJ</italic></source><volume>357</volume>:<issue>j2353</issue>. <pub-id pub-id-type="doi">10.1136/bmj.j2353</pub-id><pub-id pub-id-type="pmid">28588063</pub-id><pub-id pub-id-type="pmcid">PMC5460586</pub-id></mixed-citation></ref><ref id="B159"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ueno</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yoshino</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Mori</surname><given-names>H.</given-names></name><name name-style="western"><surname>Funahashi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kumon</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ochi</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Association study and meta-analysis of polymorphisms and blood mRNA expression of the ALDH2 gene in patients with Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">J. Alzheimers Dis</italic>.</source><volume>87</volume><fpage>863</fpage>&#8211;<lpage>871</lpage>. <pub-id pub-id-type="doi">10.3233/jad-215627</pub-id><pub-id pub-id-type="pmid">35404279</pub-id><pub-id pub-id-type="pmcid">PMC9198735</pub-id></mixed-citation></ref><ref id="B160"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van Dam</surname><given-names>F.</given-names></name><name name-style="western"><surname>Van Gool</surname><given-names>W. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Hyperhomocysteinemia and Alzheimer&#8217;s disease: A systematic review.</article-title><source><italic toggle="yes">Arch. Gerontol. Geriatr</italic>.</source><volume>48</volume><fpage>425</fpage>&#8211;<lpage>430</lpage>. <pub-id pub-id-type="doi">10.1016/j.archger.2008.03.009</pub-id><pub-id pub-id-type="pmid">18479766</pub-id></mixed-citation></ref><ref id="B161"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Venkataraman</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kalk</surname><given-names>N.</given-names></name><name name-style="western"><surname>Sewell</surname><given-names>G.</given-names></name><name name-style="western"><surname>Ritchie</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lingford-Hughes</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Alcohol and Alzheimer&#8217;s disease-does alcohol dependence contribute to beta-amyloid deposition, neuroinflammation and neurodegeneration in Alzheimer&#8217;s disease?</article-title><source><italic toggle="yes">Alcohol Alcohol</italic>.</source><volume>52</volume>:<issue>158</issue>. <pub-id pub-id-type="doi">10.1093/alcalc/agw101</pub-id><pub-id pub-id-type="pmid">28182204</pub-id></mixed-citation></ref><ref id="B162"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Visontay</surname><given-names>R.</given-names></name><name name-style="western"><surname>Rao</surname><given-names>R. T.</given-names></name><name name-style="western"><surname>Mewton</surname><given-names>L.</given-names></name></person-group> (<year>2021</year>). <article-title>Alcohol use and dementia: New research directions.</article-title><source><italic toggle="yes">Curr. Opin. Psychiatry</italic></source><volume>34</volume><fpage>165</fpage>&#8211;<lpage>170</lpage>.<pub-id pub-id-type="pmid">33394727</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/YCO.0000000000000679</pub-id></mixed-citation></ref><ref id="B163"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>B.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>S.</given-names></name><name name-style="western"><surname>He</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>The association of mitochondrial aldehyde dehydrogenase gene (ALDH2) polymorphism with susceptibility to late-onset Alzheimer&#8217;s disease in Chinese.</article-title><source><italic toggle="yes">J. Neurol. Sci</italic>.</source><volume>268</volume><fpage>172</fpage>&#8211;<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2007.12.006</pub-id><pub-id pub-id-type="pmid">18201725</pub-id></mixed-citation></ref><ref id="B164"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>D. S.</given-names></name><name name-style="western"><surname>Iwata</surname><given-names>N.</given-names></name><name name-style="western"><surname>Hama</surname><given-names>E.</given-names></name><name name-style="western"><surname>Saido</surname><given-names>T. C.</given-names></name><name name-style="western"><surname>Dickson</surname><given-names>D. W.</given-names></name></person-group> (<year>2003</year>). <article-title>Oxidized neprilysin in aging and Alzheimer&#8217;s disease brains.</article-title><source><italic toggle="yes">Biochem. Biophys. Res. Commun</italic>.</source><volume>310</volume><fpage>236</fpage>&#8211;<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2003.09.003</pub-id><pub-id pub-id-type="pmid">14511676</pub-id></mixed-citation></ref><ref id="B165"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gu</surname><given-names>B. J.</given-names></name><name name-style="western"><surname>Masters</surname><given-names>C. L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y. J.</given-names></name></person-group> (<year>2017</year>). <article-title>A systemic view of Alzheimer disease - insights from amyloid-&#946; metabolism beyond the brain.</article-title><source><italic toggle="yes">Nat. Rev. Neurol</italic>.</source><volume>13</volume><fpage>612</fpage>&#8211;<lpage>623</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2017.111</pub-id><pub-id pub-id-type="pmid">28960209</pub-id></mixed-citation></ref><ref id="B166"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Malter</surname><given-names>J. S.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>D. S.</given-names></name></person-group> (<year>2009</year>). <article-title>Effects of HNE-modification induced by Abeta on neprilysin expression and activity in SH-SY5Y cells.</article-title><source><italic toggle="yes">J. Neurochem</italic>.</source><volume>108</volume><fpage>1072</fpage>&#8211;<lpage>1082</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2008.05855.x</pub-id><pub-id pub-id-type="pmid">19196432</pub-id><pub-id pub-id-type="pmcid">PMC2693391</pub-id></mixed-citation></ref><ref id="B167"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Westerman</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Cooper-Blacketer</surname><given-names>D.</given-names></name><name name-style="western"><surname>Mariash</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kotilinek</surname><given-names>L.</given-names></name><name name-style="western"><surname>Kawarabayashi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Younkin</surname><given-names>L. H.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">J. Neurosci</italic>.</source><volume>22</volume><fpage>1858</fpage>&#8211;<lpage>1867</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.22-05-01858.2002</pub-id><pub-id pub-id-type="pmid">11880515</pub-id><pub-id pub-id-type="pmcid">PMC6758862</pub-id></mixed-citation></ref><ref id="B168"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wiegmann</surname><given-names>C.</given-names></name><name name-style="western"><surname>Mick</surname><given-names>I.</given-names></name><name name-style="western"><surname>Brandl</surname><given-names>E. J.</given-names></name><name name-style="western"><surname>Heinz</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gutwinski</surname><given-names>S.</given-names></name></person-group> (<year>2020</year>). <article-title>Alcohol and dementia - what is the link? A systematic review.</article-title><source><italic toggle="yes">Neuropsychiatr. Dis. Treat</italic>.</source><volume>16</volume><fpage>87</fpage>&#8211;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.2147/ndt.S198772</pub-id><pub-id pub-id-type="pmid">32021202</pub-id><pub-id pub-id-type="pmcid">PMC6957093</pub-id></mixed-citation></ref><ref id="B169"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williams</surname><given-names>T. I.</given-names></name><name name-style="western"><surname>Lynn</surname><given-names>B. C.</given-names></name><name name-style="western"><surname>Markesbery</surname><given-names>W. R.</given-names></name><name name-style="western"><surname>Lovell</surname><given-names>M. A.</given-names></name></person-group> (<year>2006</year>). <article-title>Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">Neurobiol. Aging</italic></source><volume>27</volume><fpage>1094</fpage>&#8211;<lpage>1099</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2005.06.004</pub-id><pub-id pub-id-type="pmid">15993986</pub-id></mixed-citation></ref><ref id="B170"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>K. M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y. R.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y. Y.</given-names></name><name name-style="western"><surname>Dong</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>L.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J. T.</given-names></name></person-group> (<year>2021</year>). <article-title>The role of the immune system in Alzheimer&#8217;s disease.</article-title><source><italic toggle="yes">Ageing Res. Rev</italic>.</source><volume>70</volume>:<issue>101409</issue>. <pub-id pub-id-type="doi">10.1016/j.arr.2021.101409</pub-id><pub-id pub-id-type="pmid">34273589</pub-id></mixed-citation></ref><ref id="B171"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>Y. Y.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y. S.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y. L.</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>W. C.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>W. M.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y. H.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Association study of alcohol dehydrogenase and aldehyde dehydrogenase polymorphism with Alzheimer disease in the Taiwanese population.</article-title><source><italic toggle="yes">Front. Neurosci</italic>.</source><volume>15</volume>:<issue>625885</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2021.625885</pub-id><pub-id pub-id-type="pmid">33551739</pub-id><pub-id pub-id-type="pmcid">PMC7862325</pub-id></mixed-citation></ref><ref id="B172"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>F.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y. G.</given-names></name><name name-style="western"><surname>Xue</surname><given-names>L.</given-names></name><name name-style="western"><surname>Li</surname><given-names>R. J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Bian</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Role of aldehyde dehydrogenase 2 Glu504lys polymorphism in acute coronary syndrome.</article-title><source><italic toggle="yes">J. Cell Mol. Med</italic>.</source><volume>15</volume><fpage>1955</fpage>&#8211;<lpage>1962</lpage>. <pub-id pub-id-type="doi">10.1111/j.1582-4934.2010.01181.x</pub-id><pub-id pub-id-type="pmid">21958412</pub-id><pub-id pub-id-type="pmcid">PMC3918050</pub-id></mixed-citation></ref><ref id="B173"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wan</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>C.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Alcohol consumption and dementia risk: A dose-response meta-analysis of prospective studies.</article-title><source><italic toggle="yes">Eur. J. Epidemiol</italic>.</source><volume>32</volume><fpage>31</fpage>&#8211;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1007/s10654-017-0225-3</pub-id><pub-id pub-id-type="pmid">28097521</pub-id></mixed-citation></ref><ref id="B174"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xue</surname><given-names>L.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Han</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Cui</surname><given-names>S.</given-names></name><name name-style="western"><surname>Dai</surname><given-names>S.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>ALDH2 mediates the dose-response protection of chronic ethanol against endothelial senescence through SIRT1/p53 pathway.</article-title><source><italic toggle="yes">Biochem. Biophys. Res. Commun</italic>.</source><volume>504</volume><fpage>777</fpage>&#8211;<lpage>783</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2018.08.081</pub-id><pub-id pub-id-type="pmid">30217444</pub-id></mixed-citation></ref><ref id="B175"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xue</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Dai</surname><given-names>S.</given-names></name><name name-style="western"><surname>Han</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Appropriate dose of ethanol exerts anti-senescence and anti-atherosclerosis protective effects by activating ALDH2.</article-title><source><italic toggle="yes">Biochem. Biophys. Res. Commun</italic>.</source><volume>512</volume><fpage>319</fpage>&#8211;<lpage>325</lpage>.<pub-id pub-id-type="pmid">30885430</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbrc.2019.03.037</pub-id></mixed-citation></ref><ref id="B176"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamashima</surname><given-names>T.</given-names></name><name name-style="western"><surname>Boontem</surname><given-names>P.</given-names></name><name name-style="western"><surname>Kido</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yanagi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Seike</surname><given-names>T.</given-names></name></person-group> (<year>2022</year>). <article-title>Hydroxynonenal causes lysosomal and autophagic failure in the monkey POMC neurons.</article-title><source><italic toggle="yes">J. Alzheimers Dis. Parkinson</italic>.</source><volume>12</volume><fpage>2161</fpage>&#8211;<lpage>2460</lpage>.</mixed-citation></ref><ref id="B177"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamashima</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ota</surname><given-names>T.</given-names></name><name name-style="western"><surname>Mizukoshi</surname><given-names>E.</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kikuchi</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Intake of &#969;-6 polyunsaturated fatty acid-rich vegetable oils and risk of lifestyle diseases.</article-title><source><italic toggle="yes">Adv. Nutr</italic>.</source><volume>11</volume><fpage>1489</fpage>&#8211;<lpage>1509</lpage>. <pub-id pub-id-type="doi">10.1093/advances/nmaa072</pub-id><pub-id pub-id-type="pmid">32623461</pub-id><pub-id pub-id-type="pmcid">PMC7666899</pub-id></mixed-citation></ref><ref id="B178"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamashima</surname><given-names>T.</given-names></name><name name-style="western"><surname>Seike</surname><given-names>T.</given-names></name><name name-style="western"><surname>Oikawa</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kido</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yanagi</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Hsp70.1 carbonylation induces lysosomal cell death for lifestyle-related diseases.</article-title><source><italic toggle="yes">Front. Mol. Biosci.</italic></source><volume>9</volume>:<issue>1063632</issue>. <pub-id pub-id-type="doi">10.3389/fmolb.2022.1063632</pub-id><pub-id pub-id-type="pmid">36819480</pub-id><pub-id pub-id-type="pmcid">PMC9936620</pub-id></mixed-citation></ref><ref id="B179"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Ge</surname><given-names>W.</given-names></name></person-group> (<year>2021</year>). <article-title>Impact of mitochondrial aldehyde dehydrogenase 2 on cognitive impairment in the AD model mouse.</article-title><source><italic toggle="yes">Acta Biochim. Biophys. Sin.</italic></source><volume>53</volume><fpage>837</fpage>&#8211;<lpage>847</lpage>. <pub-id pub-id-type="doi">10.1093/abbs/gmab057</pub-id><pub-id pub-id-type="pmid">33954430</pub-id></mixed-citation></ref><ref id="B180"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yasue</surname><given-names>H.</given-names></name><name name-style="western"><surname>Mizuno</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Harada</surname><given-names>E.</given-names></name></person-group> (<year>2019</year>). <article-title>Association of East Asian variant aldehyde dehydrogenase 2 genotype (ALDH2*2*) with coronary spasm and acute myocardial infarction.</article-title><source><italic toggle="yes">Adv. Exp. Med. Biol</italic>.</source><volume>1193</volume><fpage>121</fpage>&#8211;<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1007/978-981-13-6260-6_7</pub-id><pub-id pub-id-type="pmid">31368101</pub-id></mixed-citation></ref><ref id="B181"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yokoyama</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kato</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yokoyama</surname><given-names>T.</given-names></name><name name-style="western"><surname>Tsujinaka</surname><given-names>T.</given-names></name><name name-style="western"><surname>Muto</surname><given-names>M.</given-names></name><name name-style="western"><surname>Omori</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Genetic polymorphisms of alcohol and aldehyde dehydrogenases and glutathione S-transferase M1 and drinking, smoking, and diet in Japanese men with esophageal squamous cell carcinoma.</article-title><source><italic toggle="yes">Carcinogenesis</italic></source><volume>23</volume><fpage>1851</fpage>&#8211;<lpage>1859</lpage>. <pub-id pub-id-type="doi">10.1093/carcin/23.11.1851</pub-id><pub-id pub-id-type="pmid">12419833</pub-id></mixed-citation></ref><ref id="B182"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yokoyama</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tsutsumi</surname><given-names>E.</given-names></name><name name-style="western"><surname>Imazeki</surname><given-names>H.</given-names></name><name name-style="western"><surname>Suwa</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>C.</given-names></name><name name-style="western"><surname>Mizukami</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Salivary acetaldehyde concentration according to alcoholic beverage consumed and aldehyde dehydrogenase-2 genotype.</article-title><source><italic toggle="yes">Alcohol Clin. Exp. Res</italic>.</source><volume>32</volume><fpage>1607</fpage>&#8211;<lpage>1614</lpage>. <pub-id pub-id-type="doi">10.1111/j.1530-0277.2008.00739.x</pub-id><pub-id pub-id-type="pmid">18616675</pub-id></mixed-citation></ref><ref id="B183"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshida</surname><given-names>A.</given-names></name><name name-style="western"><surname>Dav&#233;</surname><given-names>V.</given-names></name><name name-style="western"><surname>Ward</surname><given-names>R. J.</given-names></name><name name-style="western"><surname>Peters</surname><given-names>T. J.</given-names></name></person-group> (<year>1989</year>). <article-title>Cytosolic aldehyde dehydrogenase (ALDH1) variants found in alcohol flushers.</article-title><source><italic toggle="yes">Ann. Hum. Genet</italic>.</source><volume>53</volume><fpage>1</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-1809.1989.tb01116.x</pub-id><pub-id pub-id-type="pmid">2729894</pub-id></mixed-citation></ref><ref id="B184"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yue</surname><given-names>X.</given-names></name><name name-style="western"><surname>Mei</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Tong</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Cui</surname><given-names>D.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>New insight into Alzheimer&#8217;s disease: Light reverses A&#946;-obstructed interstitial fluid flow and ameliorates memory decline in APP/PS1 mice.</article-title><source><italic toggle="yes">Alzheimers Dement.</italic></source><volume>5</volume><fpage>671</fpage>&#8211;<lpage>684</lpage>. <pub-id pub-id-type="doi">10.1016/j.trci.2019.09.007</pub-id><pub-id pub-id-type="pmid">31720368</pub-id><pub-id pub-id-type="pmcid">PMC6838540</pub-id></mixed-citation></ref><ref id="B185"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>C. E.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>W.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y. H.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>J. H.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>G. P.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain.</article-title><source><italic toggle="yes">Am. J. Pathol</italic>.</source><volume>174</volume><fpage>1481</fpage>&#8211;<lpage>1491</lpage>. <pub-id pub-id-type="doi">10.2353/ajpath.2009.081036</pub-id><pub-id pub-id-type="pmid">19264913</pub-id><pub-id pub-id-type="pmcid">PMC2671378</pub-id></mixed-citation></ref><ref id="B186"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>L.</given-names></name></person-group> (<year>2021</year>). <article-title>The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment.</article-title><source><italic toggle="yes">Acta Pharm. Sin. B</italic>.</source><volume>11</volume><fpage>1400</fpage>&#8211;<lpage>1411</lpage>. <pub-id pub-id-type="doi">10.1016/j.apsb.2021.02.008</pub-id><pub-id pub-id-type="pmid">34221859</pub-id><pub-id pub-id-type="pmcid">PMC8245805</pub-id></mixed-citation></ref><ref id="B187"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yue</surname><given-names>X.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>H.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Mei</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ai</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Illumination with 630 nm red light reduces oxidative stress and restores memory by photo-activating catalase and formaldehyde dehydrogenase in SAMP8 mice.</article-title><source><italic toggle="yes">Antioxid. Redox Signal</italic>.</source><volume>30</volume><fpage>1432</fpage>&#8211;<lpage>1449</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2018.7520</pub-id><pub-id pub-id-type="pmid">29869529</pub-id></mixed-citation></ref><ref id="B188"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>P.</given-names></name><name name-style="western"><surname>Edenberg</surname><given-names>H. J.</given-names></name><name name-style="western"><surname>Nurnberger</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lai</surname><given-names>D.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>F.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name></person-group> (<year>2022</year>). <article-title>Alcohol use disorder is associated with higher risks of Alzheimer&#8217;s and Parkinson&#8217;s diseases: A study of US insurance claims data.</article-title><source><italic toggle="yes">Alzheimers Dement.</italic></source><volume>14</volume>:<issue>e12370</issue>. <pub-id pub-id-type="doi">10.1002/dad2.12370</pub-id><pub-id pub-id-type="pmid">36419637</pub-id><pub-id pub-id-type="pmcid">PMC9677510</pub-id></mixed-citation></ref><ref id="B189"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>L.</given-names></name><name name-style="western"><surname>Miles</surname><given-names>T.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Cordero</surname><given-names>J.</given-names></name><name name-style="western"><surname>Qi</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Association of low to moderate alcohol drinking with cognitive functions from middle to older age among US adults.</article-title><source><italic toggle="yes">JAMA Netw. Open</italic></source><volume>3</volume>:<issue>e207922</issue>. <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2020.7922</pub-id><pub-id pub-id-type="pmid">32597992</pub-id><pub-id pub-id-type="pmcid">PMC7324954</pub-id></mixed-citation></ref><ref id="B190"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>S.</given-names></name><name name-style="western"><surname>Huriletemuer</surname></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wang de</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Absence of association on aldehyde dehydrogenase 2 (ALDH2) polymorphism with Mongolian Alzheimer patients.</article-title><source><italic toggle="yes">Neurosci. Lett</italic>.</source><volume>468</volume><fpage>312</fpage>&#8211;<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2009.11.022</pub-id><pub-id pub-id-type="pmid">19914339</pub-id></mixed-citation></ref><ref id="B191"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Raina</surname><given-names>A. K.</given-names></name><name name-style="western"><surname>Perry</surname><given-names>G.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>M. A.</given-names></name></person-group> (<year>2004</year>). <article-title>Alzheimer&#8217;s disease: The two-hit hypothesis.</article-title><source><italic toggle="yes">Lancet Neurol</italic>.</source><volume>3</volume><fpage>219</fpage>&#8211;<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1016/s1474-4422(04)00707-0</pub-id><pub-id pub-id-type="pmid">15039034</pub-id></mixed-citation></ref><ref id="B192"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>Z. Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y. D.</given-names></name><name name-style="western"><surname>Gong</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>W.</given-names></name><name name-style="western"><surname>Topchiy</surname><given-names>E.</given-names></name><name name-style="western"><surname>Turdi</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Mitochondrial aldehyde dehydrogenase (ALDH2) rescues cardiac contractile dysfunction in an APP/PS1 murine model of Alzheimer&#8217;s disease via inhibition of ACSL4-dependent ferroptosis.</article-title><source><italic toggle="yes">Acta Pharmacol. Sin</italic>.</source><volume>43</volume><fpage>39</fpage>&#8211;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1038/s41401-021-00635-2</pub-id><pub-id pub-id-type="pmid">33767380</pub-id><pub-id pub-id-type="pmcid">PMC8724276</pub-id></mixed-citation></ref><ref id="B193"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zilkens</surname><given-names>R. R.</given-names></name><name name-style="western"><surname>Bruce</surname><given-names>D. G.</given-names></name><name name-style="western"><surname>Duke</surname><given-names>J.</given-names></name><name name-style="western"><surname>Spilsbury</surname><given-names>K.</given-names></name><name name-style="western"><surname>Semmens</surname><given-names>J. B.</given-names></name></person-group> (<year>2014</year>). <article-title>Severe psychiatric disorders in mid-life and risk of dementia in late- life (age 65-84 years): A population based case-control study.</article-title><source><italic toggle="yes">Curr. Alzheimer Res</italic>.</source><volume>11</volume><fpage>681</fpage>&#8211;<lpage>693</lpage>. <pub-id pub-id-type="doi">10.2174/1567205011666140812115004</pub-id><pub-id pub-id-type="pmid">25115541</pub-id><pub-id pub-id-type="pmcid">PMC4153082</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>